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ABSTRACT OF THE DISSERTATION
HUMAN PAPILLOMAVIRUS VACCINE ACCEPTABILITY AMONG PARENTS OF
ADOLESCENT GIRLS IN MYSORE, INDIA
by
Abraham Degarege Mengist
Florida International University, 2019
Miami, Florida
Professor Purnima Madhivanan, Major Professor
This study examined factors that directly affect, mediate, and moderate parental
intention-to-vaccinate adolescent daughters with HPV vaccine in Mysore district, India.
A cross-sectional study was conducted among 1,609 parents of adolescent girls (778
urban and 831 rural) attending schools in Mysore between February 2010 and October
2011. A validated questionnaire in Kannada was used to assess parental attitudes and
beliefs related with HPV infection, cervical cancer, HPV vaccine and general
vaccinations. Structural equation modeling was used to estimate parameters and check if
a proposed model based on the integrative behavior theory (IBT) could fit the current
data.
More than two-thirds (78.0%) of the parents would accept vaccinating their
daughters with HPV vaccine. HPV vaccine acceptance significantly increased with an
increase in the perception of parents about the benefits (standardized regression
coefficient (β = 0.39) or sources of information about HPV vaccine (β = 0.24), but the
rate decreased significantly with an increase in the perception about barriers to HPV
vaccination (β = -0.44). The effect of beliefs about severity of HPV infection or cervical
vii

cancer (β = 0.20), and beliefs about benefits (β = 0.20) or barriers (β = -0.25) to
vaccination in general on HPV vaccine acceptance were significantly mediated by
parental attitudes or source of information about HPV vaccine. Geographical living area
significantly moderated the effect of awareness about HPV on beliefs about severity of
HPV infection or cervical cancer (β = 0.33), and the effect of religion on norms related to
HPV vaccination (β = 0.19). Fit of the proposed model to the data was acceptable. [Root
Mean Square Error of Approximation (RMSEA)= 0.025, 95% CI=0.024, 0.026;
Comparative Fit Index (CFI)=0.92 and Tucker–Lewis Index (TLI)=0.91]
In conclusion, the current study identified modifiable parental attitudes about
HPV vaccine and beliefs related with HPV infection, cervical cancer and vaccination,
which predicted parental intention-to-vaccinate their adolescent daughters with HPV
vaccine in Mysore district, India. Provision of health education interventions tailored
against negative attitudes and beliefs about HPV vaccine and vaccination in general will
be important for the Indian communities to promote HPV vaccination.
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INTRODUCTION
Cervical cancer is a major public health problem in the developing regions of the
world (Ferlay et al., 2012; Forman et al., 2012). Globally, more than 500,000 women are
estimated to be diagnosed with cervical cancer and 275,000 die annually. Almost 80% of
these cases and 88% of the deaths occur in the developing world (Ferlay et al., 2012;
Forman et al., 2012). The age-standardized incidence of the disease was estimated to be
higher in India (14.7 women per 100,000) than any other South Asian countries (13.0
women per 100,000) or the world (13.1 women per 100,000) in 2018 (Bruni et al., 2018).
Every year, about 122,844 women are diagnosed with the disease in India and 67,477 die
from it (Mishra et al., 2016). Factors such as early age at marriage, early age at first
sexual intercourse, early age at first full-term pregnancy, multiple pregnancies and longterm use of hormonal contraceptives, which facilitate the progression of HPV infection to
neoplastic cervical lesions, might have contributed to the increased incidence of cervical
cancer in India (Farooqui & Zodpey, 2012; Sreedevi et al., 2015). In addition, the cause
for increased incidence of cervical cancer in India could be the increased burden of highrisk Human papillomavirus (HPV) strains (HPV18 & HPV16) in the country (Farooqui &
Zodpey, 2012; Sreedevi et al., 2015).
There are more than 100 different HPV strains, of which 40 can be sexually
transmitted (Schiffman & Castle, 2003). It is predicted that more than 75% of sexually
active individuals will be infected with HPV during their lifetime (Schiffman & Castle,
2003). While persistent infection with high-risk HPV strains (16, 18, 31, 33, 35, 39, 51,
52, 56, 58, 59, 66, 68) can potentially cause cancer on or around the genitals, anus,
mouth, or throat; most infections are asymptomatic and clear without any interventions
1

within two years due to the body’s own immune system (Schiffman & Castle, 2003).
While HPV type 16 and 18 cause majority of cervical and anal cancers, type 6 and 11 are
reported to cause 90% of genital warts (Munoz et al., 2006).
Secondary prevention of cervical cancer using screening and treatment of
precancerous lesions is available in most developed countries (WHO, 2015). However,
due to logistical reasons, lack of infrastructure and acute shortage of skilled manpower,
cervical cancer screening programs are not readily available in most developing
countries, where the morbidity and mortality associated with the disease is high (WHO,
2015). Hence, HPV vaccination could be an additional prevention strategy to effectively
reduce the burden of cervical cancer in the developing countries (WHO, 2015).
Currently, three types of HPV vaccines (bivalent Cervarix, quadrivalent Gardasil
and nanovalent Gardasil 9) are available for preventing HPV infections (Kash et al.,
2015). The quadrivalent Gardasil (Merck & Co, New Jersey) was the first HPV vaccine
licensed for use (Kash et al., 2015). The vaccine was first approved for females aged 9 to
26 years in 2006 in USA and later for males in 2009 (Kash et al., 2015). Following that,
Cervarix (GlaxoSmithKline (Rixensart, Belgium)) was licensed for females in 2007 in
Australia, the European Union and Philippines, and later in other countries of the world
(Kash et al., 2015). In 2014, Gardasil 9, a new vaccine, was approved for females and
males in USA (Kash et al., 2015). Gardasil prevents four strains of HPV (6,11,16,18) and
Cervarix is effective against two strains of HPV 16 and 18 (Kash et al., 2015). Gardasil 9
is effective against nine strains of HPV (6, 11, 16, 18, 31, 33, 45, 52, and 58) (Kash et al.,
2015). These three vaccines are administered in two (if the first dose is taken before the
age of 15) or three (if the first dose is taken at or after the age of 15 years or among
2

immunocompromised individuals) doses over a six to 12-month period (HPV Vaccine,
New Recommendation, 2010). Gardasil and Cervarix vaccines are safe, effective (90% to
100%) and prevent up to 70% of cervical cancers for up to seven years, if given to
individuals’ naïve to infection (De Vincenzo et al., 2014). However, the safety and
efficacy of Gardasil 9 vaccine is not well studied.
Although HPV vaccines were shown to be safe and effective; the rate of uptake
among at risk-individuals was not as high as anticipated, lowering its potential public
health impact. Studies speculated several factors that could potentially hinder an
individual’s uptake of the vaccine, which include: i) intrapersonal factors such as
knowledge, belief and attitude about HPV, cervical cancer and HPV vaccine; and
sociodemographic factors that affect the individual’s decision making process (Hofstetter
& Rosenthal, 2014; Galbraith et al. 2016; Radisic et al. 2017); ii) interpersonal factors
such as peers, partner/marital status, families, health care providers or doctors or health
officials (Dempsey et al., 2009; Gerend et al., 2009; Gottlieb et al., 2009; Caskey et al.,
2009); and iii) Environmental/structural/political factors (Cunningham et al., 2015;
Eberhardt & Pamuk, 2004; Belani et al., 2014). A clear understanding of factors that may
be responsible for influencing vaccine uptake in a specific community would help to
implement vaccination programs successfully and achieve maximum coverage.
In order to effectively control cervical cancer, the government of India approved
HPV vaccination for females aged 9 to 26 years in 2008 (IAPCOI, 2008). However,
introducing HPV vaccine in India has had unique challenges due to unfounded concerns
about the efficacy and safety of the vaccine leading to suspension of the HPV vaccination
in 2010 (Larson et al., 2010; Lamontagne & Sherris, 2013). Recently, the government of
3

India has decided to include HPV vaccine in the National Immunization Programme
(Vashishtha et al., 2014; Chatterjee et al., 2016).
There is, however, limited information on the uptake of the vaccine. HPV
vaccination uptake might be low due to misperceptions about HPV infection, cervical
cancer and HPV vaccine or due to different moral and cultural reasons in India
(Madhivanan et al., 2009; Paul et al., 2014; Basu & Mittal, 2011). There is a need to
investigate factors that are related to HPV vaccine acceptability among parents in India.
This will help design evidence-based strategies to achieve maximum HPV vaccine
coverage by the target groups, when the National Immunization Programme starts.
Few studies have been conducted to assess the determinants of HPV vaccine
acceptance among adolescents and parents in India (Madhivanan et al., 2009; Paul et al.,
2014; Basu & Mittal, 2011). As there is great diversity in social practices, ethnicity,
culture, religion and economic composition, determinants of HPV vaccine acceptability
are expected to vary geographically in India. Thus, studies in various populations are
necessary to design appropriate evidence-based interventions and vaccine delivery
strategies to achieve maximum vaccine acceptance on the Indian subcontinent.
The economic and education level of populations, and the nature of socio-cultural
and physical environments, which may affect different health outcomes, tend to vary
between rural and urban regions in India (Hnatkovska & Lahir, 2017). The level of access
to media, medical services, medical professionals and health insurance might be lower in
rural than urban regions in the country due to poorer healthcare infrastructure (Balarajan
et al., 2011). Thus, we hypothesized that the attitude and beliefs of parents towards
cervical cancer, HPV infection and HPV vaccine may not be similar in rural and urban
4

regions in India. As a result, determinants of intention to accept HPV vaccination for
adolescents may not be similar among parents living in rural and urban areas in India.
However, studies on HPV vaccine acceptability are very limited in rural areas in India.
Hence, the objective of this dissertation was to assess the factors that predict intention to
receive HPV vaccine among urban and rural parents in Mysore, India. In order to achieve
this objective, we have conducted three studies. The first study compared parental
attitudes and beliefs related to HPV infection, cervical cancer and HPV vaccine between
urban and rural residents in Mysore, India. The second study examined factors associated
with HPV vaccine acceptability among parents of adolescent girls in rural area Mysore,
India. The third study examined the moderating effect of living area on the relationship of
socioeconomic status with parental beliefs related to HPV infection, cervical cancer and
vaccination, and the mediating effect of parental attitudes related to HPV vaccine on the
relationship of beliefs related to HPV infection, cervical cancer and vaccination with
HPV vaccine acceptability. In addition, the third study tested whether a proposed model
based on the integrative behavior theory (IBT) could fit the current data and determined
the reliability and validity of items used to measure different latent variables
hypothesized to affect HPV vaccine acceptability.
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MANUSCRIPT 1
© Copyright 2018
Degarege, A., Krupp, K., Fennie, K., Li, T., Stephens, D.P., Marlow, L.A.V., Srinivas,
V., Arun, A., & Madhivanan P. (2018). Urban-rural inequities in the parental attitudes
and beliefs towards Human papillomavirus infection, cervical cancer and HPV vaccine in
Mysore, India. J Pediat Adolesc Gynecol, 31(5):494-502.
Abstract
Objective: The aim of this study was to compare the parental attitudes and beliefs about
HPV, cervical cancer and HPV vaccine between urban and rural areas, India.
Methods: A cross-sectional study was conducted among parents of school going
adolescent girls in urban (between February, 2010 and January, 2011) and rural
(September and October, 2011) areas in Mysore district, India. A self-administered
questionnaire in English and Kannada was used to collect information about the sociodemographic characteristics, parental attitudes and beliefs about HPV infection, cervical
cancer and HPV vaccine.
Results: A total of 1609 parents from urban (n=778) and rural (n=831) areas participated
in this study. Majority of the parents had never heard about HPV (73.6%), did not know
that their daughters could get an HPV infection (62.7%) or cervical cancer (64.1%) in the
future, and believed that HPV vaccine was not effective (67.1%). Parents living in the
urban area were more likely to believe that HPV infection (adjusted Odds Ratio (aOR)
2.69; 95%CI:1.43, 5.06) and cervical cancer (aOR 2.68; 95%CI:1.83, 3.91) could cause
serious health problems than those living in the rural area. The odds of agreeing that HPV

9

vaccination will make girls sexually active was lower among urban than rural parents
(aOR 0.55; 95%CI:0.33, 0.94). There was no significant difference among parents in the
urban and rural areas in their beliefs about susceptibility of their daughter to HPV
infection or cervical cancer, and beliefs about the safety and ability of HPV vaccine to
protect cervical cancer.
Conclusions: Rural parents might be reluctant to recommend behaviors that can help
prevent HPV infection and cervical cancer such as HPV vaccination for their daughters.
Key words: Attitudes, Beliefs, Cervical Cancer, HPV infection, HPV vaccine, India
Introduction
Globally, an estimated 528,000 or more women are diagnosed with cervical
cancer and 275,000 die each year (GLOBOCAN, 2012). Almost 80% of these cases and
88% of the deaths occur in the developing world (GLOBOCAN, 2012). The agestandardized annual incidence of the disease was estimated to be higher in India (22
women per 100,000) than other South-Asian countries (19.3 women per 100,000) or the
world (14 women per 100,000) in 2012 (Bruni et al., 2016). Factors such as early age at
marriage, early age at first sexual intercourse, early age at first full-term pregnancy,
multiple pregnancies and long term use of hormonal contraceptives, which facilitate the
progression for HPV infection to neoplastic cervical lesions, may contribute to the
increased incidence of cervical cancer in India (Sreedevi et al., 2015). In addition, the
cause for the increased incidence of cervical cancer in India could be the increased
burden of high-risk HPV strains in the country, with HPV-18 & 16 being the most
common (Sreedevi et al., 2015).
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There are more than 170 different HPV strains, of which 40 can be sexually
transmitted. It is predicted that >75% of sexually active individuals will be infected with
HPV during their lifetime (Schiffman and Castle, 2003; Yudin, 2010). While persistent
infection with high-risk HPV strains (11, 16, 18, 33,51, 52, 53, 58, 61) can potentially
cause cancer or warts on or around the genitals, anus, mouth, or throat; most infections
are asymptomatic and clear without any interventions within two years due to the body’s
own immune system (Schiffman and Castle, 2003; Hager, 2009). HPV type 16 and 18
cause the majority of cervical and anal cancers, while type 6 and 11 cause 90% of genital
warts (Munoz et al., 2006).
Currently, three types of HPV vaccines (Cervarix, Gardasil and Gardasil 9) are
available for preventing HPV infections (Harper & DeMars, 2017). Gardasil prevents
four strains of HPV (6,11,16,18). Cervarix is effective against two strains (16 and 18) and
Gardasil 9 is effective against nine strains of HPV (6, 11, 16, 18, 31, 33, 45, 52, and 58)
(Harper & DeMars, 2017; Tyson, 2017). The three vaccines are safe and effective (90%
to 100%) (Harper & DeMars, 2017; Tyson, 2017). Cervarix and Gardasil potentially
prevents 75% of cervical cancers related to HPV 16 and18, and Gardasil 9 prevents 89%
of cancers related to HPV 16,18,31,33,45,52 and 58 (Hartwiga et al., 2015). In addition,
Gardasil potentially prevents 47% pre-cancerous lesions related to HPV 6,11,16, 18 and
Gardasil 9 prevents 82.0% of pre-cancerous lesions related to HPV 16,18,31,33,45,52
and 58 (Hartwiga et al., 2015).
Although HPV vaccines have been shown to be safe and effective; the rate of
uptake among at-risk individuals is not as high as anticipated, lowering its potential
public health impact. HPV vaccination was even suspended in India until recently after
11

being approved in 2008 (IAPCOI, 2008). The factors that contributed to the suspension
of HPV vaccination in India included lack of knowledge and misinformation about HPV,
cervical cancer and HPV vaccine; negative attitudes and beliefs about HPV, cervical
cancer and HPV vaccine; and sociodemographic and cultural factors (IAPCOI, 2008).
Indeed, health behavior theories indicate that knowledge, sociodemographic and cultural
factors affect attitudes and beliefs of people to a disease pathogenesis, treatment and
prevention measures (Champion & Skinner, 2008; Fishbein, 2009). The attitudes and
beliefs of individuals towards a disease, in turn influences the behavior of individuals to
prevent a disease (Champion & Skinner, 2008; Fishbein, 2009).
As the economic and education level of populations, and the nature of sociocultural and physical environments, tend to vary between urban and rural areas
(Eberhardt & Pamuk, 2004), we hypothesized that the attitudes and beliefs of individuals
towards HPV infection, cervical cancer and HPV vaccine are not similar among residents
in urban and rural areas. However, evidence is limited to support this notion.
Understanding the attitudes and beliefs of individuals about HPV infection, cervical
cancer and HPV vaccine will help to inform the design of appropriate public health
programs to prevent cancer. The information will be particularly important in rural areas,
where 68.4% of the Indian population lives, and death rates due to cervical cancer are
high (Dikshit et al., 2012). Given that previous studies have focused mostly on urban
populations (Madhivanan et al., 2009; Ramavath & Olyai, 2013), the objective of this
study was to compare parental attitudes and beliefs about HPV infection, cervical cancer
and HPV vaccine between urban and rural areas in Mysore district, India.
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Methods
Study area
A cross-sectional study was conducted among parents of school going adolescent
girls who were living in urban and rural regions in Mysore district, India. Data from
urban parents were collected between February, 2010 and January, 2011, and data from
rural parents were collected between September and October, 2011. Mysore district is
located in the southern part of the state of Karnataka, south west India. It ranks third in
terms of population size (3,001,127, density: 450/km2) among 30 districts in the state
(Census, 2011). (Fig 1). Majority of the population (1,755,714) in Mysore district live in
the rural areas (Census, 2011). Age-standardized annual cervical cancer mortality rate in
Karnataka was 16.5 per 100, 000 in 2010 (Dikshit et al., 2012).
[Insert figure 1 here]
Sampling techniques
A total of 1,609 parents (778 urban and 831 rural) were involved in this study.
Twelve schools (five government, four private and three religious) in Mysore city and 11
schools (10 government and 1 private) in rural Mysore Taluk were selected based on
probability proportionate to size. First a program announcement was sent home with all
girls attending 7th through 10th grades in the selected schools explaining the study and
inviting eligible parents to participate. Then all girls aged 11 to 15 years in these schools
were enumerated and 1631 female students randomly selected and provided with a
questionnaire to take to their parents, who filled them out and returned within seven days.
Only one parent in a family filled out the questionnaire. Only 2.7% of parents in the
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urban area and 2.2% parents in the rural area failed to return the completed questionnaire
along with the signed consent form.
Questionnaire and measures
A self-administered questionnaire in English and Kannada was used to collect
information about the socio-demographic characteristics, awareness about HPV, source
of information about HPV vaccine, attitude and beliefs of parents about HPV infection,
cervical cancer and HPV vaccine. The questionnaire contained 126 items, however only
26 items were selected for the analysis of this study based on the integrated model for
behavior (IMB) (Fishbein, 2009) and the health belief model (HBM) (Champion &
Skinner, 2008). Out of 26, 15 items contained information on hypothesized correlates of
attitudes and believes about HPV infection, cervical cancer and HPV vaccine (age,
gender, employment, education, religion, marital status, area of residence, HPV
awareness, source of information about HPV vaccine) based on literature, IMB and HBM
(Fishbein, 2009; Champion & Skinner, 2008). The items were validated and used in
previous studies (Witte, 1996; Marlow et al., 2007). Parental awareness about HPV was
assessed by asking the question “Have you ever heard of HPV”. Responses were recoded
as ‘yes’ and ‘no’. Source of information about HPV vaccine was collected using eight
items (Television, Newspaper or Radio, Internet, Doctor, ANM or Anganwadi teacher or,
Worker, Friends or Neighbors, My daughter's school, Family member or relatives).
Responses were recorded on a four point scale (1=never, 2= not often, 3= often, 4=very
often), but were dichotomized into ‘no’ (never) and ‘yes’(very often, often, not often)
during data analysis.
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The remaining 11 items were used to assess information on parental attitude and
beliefs about HPV infection, cervical cancer and HPV vaccine. Out of the 11 items, four
were used to assess parental attitudes towards susceptibility to cervical cancer (‘It is
possible that my daughter will get cervical cancer in the future’ and ‘It is likely that my
daughter may get cervical cancer someday’ (Cronbach’s alpha (α)= 0.73) and HPV
infection (‘It is likely that my daughter will get HPV in the future’ and ‘My daughter may
be at-risk of getting HPV infection’ α= 0.72). Other four items were used to assess beliefs
towards severity of cervical cancer (‘I believe that cervical cancer is serious disease’ and
‘I believe that cervical cancer can be extremely harmful’, α= 0.65) and HPV infection (‘I
believe that HPV infection can cause serious health problem’ and ‘I believe that HPV
infection can be extremely harmful’, α= 0.63). Responses to these eight items were
recorded a on a three-point scale (1=disagree, 2=Do not know, 3=Agree).
The remaining three items (out of the 12) were used to collect information about
parental attitudes about HPV vaccine (‘HPV vaccine is safe’, ‘HPV vaccine will prevent
cervical cancer’ and ‘daughter receiving HPV vaccine may become sexually active’).
Responses to the items ‘HPV vaccine is safe’ and ‘HPV vaccine will prevent cervical
cancer’ were recorded on a three-point scale (‘very important’, ‘important’ and ‘not
important at all’). Similarly, responses to the questions about beliefs on whether HPV
vaccination will make girls sexually active was recorded on a three-point scale (1=
‘disagree’, 2=‘do not know’, 3=‘agree’) .
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Ethical consideration
Ethical approval to conduct this study was obtained from the Institutional Review
Boards at Florida International University and Public Health Research Institute of India.
The Block Education officer and school administrators were also asked for their
permission to conduct the study. Only parents who provided written informed consent
were included in the study.
Data analysis
Data were entered into an MS Access database, checked for completeness and
analyzed using Stata software (Version 14, Texas, USA). The outcome variables were: i)
parental attitudes about susceptibility of daughter to HPV infection, and susceptibility to
cervical cancer (continuous); ii) parental belief about severity of HPV infection and
cervical cancer (continuous) and; iii) parental attitude that HPV vaccine is safe (yes, no)
and that HPV vaccine prevents cervical cancer (yes, no) and makes adolescents sexually
active (disagree, do not know, agree). The main exposure variable was geographical area
(0=rural, 1=urban). Other explanatory variables included: sex (0=male, 1=female), age in
years (continuous), marital status (0=unmarried, 1= married), religion (0=Hindus,
1=Muslims, 2=Christians/others), employment (0= Retired/unemployed, 1= Employed
part-time, 2=Employed fulltime, 3=Self-employed, 4= Full time homemaker) and
educational status (0=No formal education, 1=Grade1 to 10 th, 2=High school or bachelor
degree, 4=Vocational training (diploma), 5=Master degree or above) of parents and their
awareness about HPV (0=no, 1=yes) and source of information about vaccines. Parental
response to questions assessing their beliefs about the safety of HPV vaccine and its
importance to protect cervical cancer was originally recorded in three categories as ‘very
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important’, ‘important’ and ‘not important at all’. However, the three categories were
merged into two during data analysis as ‘yes’ (very important and important) and ‘no’
(not important at all).
Percentages were used to describe the frequency of parental responses to
questions addressing beliefs and attitudes towards cervical cancer, HPV infection and
HPV vaccine. Chi-square test was used to check if there was a relationship between
sociodemographic factors and parental attitudes and beliefs towards cervical cancer, HPV
infection and HPV vaccine. Because of potential clustering of parental beliefs towards
HPV vaccine by the school that the daughters attended, a Generalized Estimating
Equations (GEE) using logit function (Stata command= xtgee) was used to test the
hypothesis that area of residence is associated with parental attitudes about HPV vaccine
(safety, protective ability against cervical cancer, belief that HPV vaccination make
daughters sexually active). Similarly, a multinomial regression that accounts school as a
clustering variable was used to test the hypothesis that area of residence was associated
with parental attitudes about susceptibility of daughters to HPV infection or cervical
cancer, and parental belief about severity of HPV infection or cervical cancer. Values for
the within-school correlation matrix ranged from 0.012 to 0.067 for the different
outcomes. Odds ratios (OR) were calculated along with their associated 95% confidence
interval (CI).
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Results
Characteristics of the study participants
Of the 800 parents contacted in the urban area, 778 (97.3%) returned the
completed questionnaire along with the signed consent forms, and 831 (97.8%) of the
850 parents contacted in the rural area returned the completed questionnaires along with
the signed consent forms. The mean age (± standard deviation) of the study participants
was 38.3±6.58 years. Majority of them were female (73.0%), Hindu by religion (88.9%),
employed (54.8%), educated (60.0%), and married (93.0%). There were significant
differences in the composition of participants between urban and rural regions in terms of
gender, age, education, occupation, religion and marital status (Table 1). The proportion
of parents who were female, aged younger than 35 years and employed part-time were
lower in the urban area than in the rural area (p<0.01 for all). The proportion of parents
who were married, Muslim, educated and full-time employees were greater in the urban
area than the rural region (p<0.01 for all). About 71.6% of urban parents and 75.5% of
rural parents had never heard about HPV. The proportion of parents who got information
about HPV vaccine from television, newspaper or radio, internet or doctor was greater in
urban than rural region (p<0.01 for all).
[Insert Table 1 here]
Parental attitudes and beliefs about HPV infection, cervical cancer and HPV vaccine
Majority of the parents did not know that their daughters could be at-risk for HPV
infection (58.2%) or cervical cancer (64.1%) in the future. However, majority of the
study participants believed that HPV infection (65.3%) and cervical cancer (68.9%) could
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cause serious health problems. Majority of the parents also believed that HPV vaccine
was safe (90.6%) and could prevent cervical cancer (90.0%). In addition, 21% agreed that
HPV vaccination would make girls sexually active.
Greater percentage of parents in the rural region than in the urban region indicated
that they did not know whether their daughter was at-risk of getting HPV infection
(62.9% vs 53.2%, p<0.001) or cervical cancer (66.8% vs 61.2%, p=0.02). Similarly, the
percentage of parents who did not know, and the percentage of parents who disagreed
that HPV infection or cervical cancer could cause serious health problems was greater
among rural residents than in the urban region (Table 2). However, parents living in the
urban area tended to agree that HPV infection (74.2% vs 57.0%, p<0.001) or cervical
cancer (78.7% vs 59.7%, p<0.001) caused serious health problems more often than
parents in the rural area (Fig 2). The percentage of parents who agreed that HPV vaccine
would make girls sexually active were greater among residents in the rural region than
the urban one (23.5% vs 18.5%, p=0.001).
[Insert table 2 here]
[Insert figure 2 here]
Factors associated with parental attitudes and beliefs about HPV infection, cervical
cancer and HPV vaccine
Urban parents were more likely to believe that HPV infection could cause serious
health problems (aOR 2.69; 95%CI 1.43, 5.06) or that it can be extremely harmful (aOR
1.81; 95%CI 1.08, 3.04) than rural parents. Similarly, parents living in the urban area
were more likely to believe that cervical cancer is a serious disease (aOR 2.68; 95%CI
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1.83, 3.91) or that it can be extremely harmful (aOR 2.28; 95%CI 1.26, 4.12) than those
living in the rural area. Parents living in the urban region also had lower odds of agreeing
that HPV vaccination will make girls sexually active than those in the rural region (aOR
0.55; 95% CI 0.33, 0.94). However, there was no significant difference among urban and
rural parents in their beliefs about safety of HPV vaccine and ability of the vaccine to
prevent cervical cancer (Table 3). Furthermore, parental perception about the perceived
susceptibility of their daughter to get HPV infection and cervical cancer was not
significantly different between urban and rural parents (Table 3).
[Insert table 3 here]
Discussion

This study compared the parental attitudes and belief about HPV infection,
cervical cancer and HPV vaccine among urban and rural areas of Mysore district, India.
The study showed evidence of urban-rural differences in the parental attitudes and beliefs
about HPV, cervical cancer and HPV vaccine. When compared to parents living in rural
regions, urban parents were more likely to believe that HPV infection and cervical cancer
caused serious health problems. In addition, urban parents were less likely to agree that
HPV vaccination will make girls sexually active
The increased tendency of urban parents to believe that HPV infection and
cervical cancer could cause serious health problems could be due to their knowledge
about severity and morbidities related to HPV infection and cervical cancer. In one study
of a school population, the proportion who knew about cervical cancer and HPV infection
was greater in urban than rural areas of Noida and Delhi, India (Hussain et al., 2014).
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Although the difference was not significant, a relatively larger number of parents in the
urban region compared to those in the rural region had ever heard of HPV in the current
study. In addition, majority (>85%) of the parents living in the urban region had formal
education and more than 30% had more than high school education. However, only
36.6% of rural parents had formal education and only 2.3% had more than high school
education. Literacy rates in India are also greater among urban than rural populations
(Das & Pathak, 2012). Furthermore, different media such as radio and television, and
health care centers, which could be potential sources of correct information about HPV
and cervical cancer, are more common in urban areas (Das & Pathak, 2012). Hence,
parents in urban areas may have better knowledge about HPV and this may have
positively influenced their beliefs about the severity of HPV infection and cervical
cancer. However, in Tanzania, the proportion of individuals who believed that cervical
cancer is fatal was lower in urban than rural area (Cunningham et al., 2015). The
variation on the type of items used for assessing beliefs around severity of cervical cancer
could be a reason for the difference (cervical cancer is fatal vs ‘I believe that cervical
cancer is serious disease’ and ‘I believe that cervical cancer can be extremely harmful’).
A study in USA reported contradictory results on the beliefs about severity of colorectal
cancer, when data were analyzed based on the responses for two items (Hughes et al.
2015). Rural residents were more likely to agree that colorectal cancer was severe than
urban residents, when data were analyzed based on the response to the item ‘colorectal
cancer would change whole life’. However, rural residents were less likely to agree that
colorectal cancer was severe when data were analyzed based on the response to the item
‘would not live longer than five years if I develop colorectal cancer’.
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Similarly, the reduced odds of the belief that HPV vaccine makes girls sexually
active among urban parents could be due to a greater knowledge about HPV vaccine in
the urban area. Urban parents may know better and communicate the knowledge to their
daughter, that HPV vaccine protects only some strains of HPV infection (Harper &
DeMars, 2017). In addition, urban parents may think that their daughter would get
information about HPV vaccine from different reliable sources, thus decreasing their
perception that HPV vaccination would lead to increased sexual activity. A study in
northern India found that greater proportion of individuals in urban than in rural areas of
Noida and Delhi were aware of the HPV vaccine (Hussain et al., 2014). Urban women in
Wardha district, located in the northeastern part of the state of Maharashtra also reported
more positive attitudes towards breast cancer treatment and screening as compared to
rural women (Gangane et al., 2015).
While majority (≥90%) of study participants believed that HPV vaccine was safe
and could protect against cervical cancer in both urban and rural areas; 18.5% of the
urban parents and 23.5% of rural parents believed that HPV vaccination will make girls
sexually active and over half of the parents in both areas did not know if HPV
vaccination will make girls sexually active. As HPV vaccination targets adolescents aged
11-12 years to prevent cervical cancer and genital warts (Tyson, 2017), parents fear that it
would give girls a false sense of security against infection with sexual transmitted
infections other than HPV, and encourage them to become sexually active or practice
risky sexual behavior if they are already sexually active (Tanday, 2014). Thus, parents
might be reluctant to recommend HPV vaccination for their daughter. Hence, educational
programs that can create awareness about infections that can be protected by HPV
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vaccine are necessary for both urban and rural area in Mysore, India. In addition,
previous research findings, which confirmed that HPV vaccination does not affect sexual
activity in USA, Europe, Africa and South America (Tanday, 2014; Hansen et al., 2014;
Rysavy et al., 2014; Turiho et al., 2015; Ruiz-Sternberg & Pinzón-Rondón, 2014), should
be communicated to parents to increase their trust that HPV vaccination will not change
the sexual behavior of their daughters. Rather, HPV vaccination may increase awareness
of sexually transmitted infections, sexual health (e.g. condom use) and importance of pap
smear screening (Ruiz-Sternberg & Pinzón-Rondón, 2014; Ports et al., 2014;
Sopracordevole et al., 2013). Moreover, informing parents about the study findings by
Grimaldi-Bensouda et al., (2017), and Jefferson and Jørgensen (2017), which showed
lack of association between HPV vaccination and autoimmune disease, would increase
their trust on the safety of the vaccine. This will further increase parental acceptance of
HPV vaccination for their daughters. However, studies are necessary to make firm
conclusion whether HPV vaccination will not affect adolescent sexual behavior in India
population.
Almost three-quarters of the parents living in both the urban (71.6%) and rural
(75.4%) areas had never heard of HPV. A study among women in Odisha, India reported
lack of awareness about HPV by the majority of study participants (68.8%) (Khanna et
al., 2015). This relatively high level of unawareness about HPV in India is however
lower, when compared to reports from other Asian countries. For example, the proportion
of women who were unaware of HPV was 84.5% in a sample of six community clusters
from three major cities (Shenyang, Shanghai and Beijing) and rural areas (Shanxi,
Xinjiang and Henan) in China (Li et al., 2009), and 88.4% in rural villages in states of
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Perak and Pahang in Malaysia (Wong, 2011). About 74% parents of children aged 10-13
years were also unaware of HPV in the town Ankara, Turkey (Seven et al., 2015).The
relatively greater rate of HPV awareness observed among the Indian parents could be due
to increased media coverage associated with the demonstration study conducted in the
country from 2009 to 2011, to study feasibility and appropriate delivery strategies of
HPV vaccine for girls (Lamontagne & Sherris, 2013). Knowledge about HPV affects the
acceptability of HPV vaccine by individuals (Patel et al., 2016). Thus, provision of HPV
and health education in the community will be paramount to help increase uptake of the
HPV vaccine in future government initiatives to include HPV vaccine in the national
immunization program (Chatterjee et al., 2016; Vashishtha et al., 2014). Some states
(Punjab, Delhi) in India have already included HPV vaccination in the immunization
programme (WHO, 2017; Chatterjee, 2017).
To our knowledge, this is the first Indian study that assessed urban-rural
differences and determinants of parental attitudes and beliefs about HPV, cervical cancer
and HPV vaccine. These results will be useful when designing interventions to combat
HPV infection and cervical cancer, and increase HPV vaccine uptake by target groups in
rural and urban regions. The study involved a relatively large sample size with a response
rate of over 95%. This should increase the generalizability of the findings to target
populations in India. However, this study was not without limitations: data were selfreported and there could be information bias as parents may have gotten support from
other family members or friend when they responded to the questionnaire. In addition,
the rural data were collected seven months after the urban data were collected, which
may affect the findings of the study. The rural parents may acquire knowledge about
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HPV, cervical cancer and HPV vaccine during this period, particularly because HPV
vaccine was approved in 2008 in India (IAPCOI, 2008). This may introduce bias to the
current results underestimating the observed difference in the parental attitudes and
beliefs about HPV, cervical cancer and HPV vaccine between urban and rural residents.
Conclusions
Rural parents might be reluctant to make decisions that can help prevent HPV
infection and cervical cancer such as HPV vaccination for their daughters. Provision of
health education about the different types of cancers caused by HPV infection that can be
effectively prevented through HPV vaccination is necessary for rural Indian parents.
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Table 1. Sociodemographic characteristics of rural and urban parents of adolescent girls
in Karnataka, India 2010/2011 (n=1609)
Variables

Categories

Urban

Rural

X2-p-

(n=778)

(n=831)

value

Sex

<0.001
Female

69.0

76.8

Male

31.0

23.2

Age in years

<0.001
≤35

31.1

53.3

36-40

33.0

27.4

41-50

31.8

15.5

>50

4.1

3.7

Education

<0.001
No formal education

14.9

63.4

Grade1 to 10th

50.6

34.3

High school or bachelor

24.3

1.8

5.1

0.4

5.0

0.1

degree
Vocational training
(diploma)
Master degree or above
Employment

<0.001
Employed fulltime

27.5

7.0

Employed part-time

10.7

43.0

Self-employed

14.4

7.0

Full time homemaker

43.6

41.8

Retired/unemployed

3.9

1.3

Marital status

0.010
Married

94.7

91.5

Unmarried

5.3

8.5

Religion

<0.001
30

Hindu

78.0

99.0

Islam

18.8

1.0

Christian/other

3.2

0.0

Have you ever heard

0.079

about HPV?
Yes

28.4

24.6

No

71.6

75.4

90.0

81.1

9.0

18.3

88.7

75.3

10.0

24.2

59.0

43.9

37.7

53.3

91.3

87.6

7.5

11.7

ANM or Anganwadi Yes

70.7

80.4

teacher or Worker No

26.3

17.8

Friends or Neighbors Yes

77.5

68.9

20.3

30.1

91.8

93.6

8.2

6.4

78.4

69.2

20.4

30.0

Source of information about vaccines
Television Yes
No
Newspaper or Radio Yes
No
Internet Yes
No
Doctor Yes
No

No
My daughter's school Yes
No
Family member or Yes
relatives No

<0.001

<0.001

<0.001

0.005

<0.001

<0.001

0.193

<0.001

Notes: Values in the tables are percentages. Percentages may not add up to 100 due to
missing data
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Table 2. Comparison of the attitudes and beliefs about HPV infection, cervical cancer and
HPV vaccine between rural and urban parents of adolescent girls in Mysore district, India
2010/2011(n=1609)
Attitudes and beliefs

Response

Urban

Rural

(n=778)

(n=831)

Susceptibility to HPV

Disagree

30.3

23.4

My daughter may be at-risk of getting

Do not know

53.2

62.9

HPV infection

Agree

16.5

13.7

It is likely that my daughter may get

Disagree

23.65

20.70

HPV infection in the future

Do not know 60.54

64.74

Agree

15.81

14.56

Susceptibility to cervical cancer

Disagree

22.6

21.1

It is possible that my daughter will get

Do not know

61.2

66.8

cervical cancer in the future

Agree

16.1

12.2

It is likely that my daughter may get

Disagree

25.5

22.14

cervical cancer someday

Do not know

59.3

63.90

Agree

15.2

13.96

Severity of HPV

Disagree

4.0

8.9

I believe that HPV infection can cause

Do not know

21.9

34.1

serious health problem

Agree

74.2

57.0

I believe that HPV infection can be

Disagree

6.04

10.11

extremely harmful.

Do not know 18.64

27.20

Agree

75.32

62.70

Severity of cervical cancer

Disagree

5.3

10.8

I believe that cervical cancer is a

Do not know

16.1

29.5

serious disease

Agree

78.7

59.7

I believe that cervical cancer can be

Disagree

4.8

8.8

extremely harmful.

Do not know

15.9

28.3
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p-value

<0.001

0.209

0.033

0.160

<0.001

<0.001

<0.001

<0.001

Agree

79.3

62.9

No

7.2

8.4

Yes

92.2

91.6

HPV vaccine will prevent cervical

No

8.5

9.3

cancer

Yes

90.0

90.0

Having the HPV vaccination might

Disagree

23.7

16.7

make girls more likely to have sex

Do not know

56.3

58.6

Agree

18.5

23.5

Attitudes about HPV vaccine
HPV vaccine is safe

0.387

0.617

0.001

Notes:
Values in the tables are percentages
Percent values for some items categories do not add up to 100 due to missing data
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Table 3. Comparison of the attitudes and beliefs about HPV infection, cervical cancer and
HPV vaccine among urban versus rural parents in Mysore district, India
2010/2011(n=1609)
Attitudes and beliefs: Items

Response

Crude OR (95% CI)

Adjusted OR
(95% CI)

Susceptibility to HPV

Disagree

My daughter may be at-risk of

Do not know 0.65 (0.52, 0.82)

0.66 (0.41, 1.07)

getting HPV infection

Agree

0.92 (0.67, 1.26)

0.65 (0.35, 1.22)

It is likely that my daughter may

Disagree

get HPV infection in the future

Do not know 0.82 (0.64, 1.04)

0.88 (0.58, 1.33)

Agree

0.95 (0.69, 1.320

0.74 (0.44, 1.24)

Susceptibility to cervical cancer

Disagree

It is possible that my daughter

Do not know 0.85 (0.67, 1.09)

0.90 (0.59, 1.38)

will get cervical cancer in the future Agree

1.23 (0.88, 1.72)

1.28 (0.68, 2.43)

It is likely that my daughter may

Disagree

get cervical cancer someday

Do not know 0.81 (0.64, 1.02)

0.78 (0.54, 1.14)

Agree

0.94 (0.68, 1.31)

0.86 (0.51, 1.45)

Severity of HPV

Disagree

I believe that HPV infection can

Do not know 1.43 (0.90, 2.27)

1.66 (0.78, 3.53)

cause serious health problem

Agree

2.91 (1.88, 4.50)

2.69 (1.43, 5.06)

I believe that HPV infection can

Disagree

be extremely harmful

Do not know 1.15 (0.76, 1.73)

1.30 (0.82, 2.04)

Agree

2.01 (1.38, 2.92)

1.81 (1.08, 3.04)

Severity of cervical cancer

Disagree

I believe that cervical cancer is a

Do not know 1.12 (0.73, 1.72)

1.78 (1.21, 2.63)

serious disease

Agree

2.71 (1.84, 3.99)

2.68 (1.83, 3.91)

I believe that cervical cancer can

Disagree

be extremely harmful.

Do not know 1.04 (0.66, 1.64)

1.49 (0.76, 2.95)

Agree

2.28 (1.26, 4.12)

2.33 (1.54, 3.52)
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Attitudes about HPV vaccine
HPV vaccine is safe

No
Yes

1.15 (0.70, 1.91)

0.73 (0.41, 1.29)

1.05 (0.52, 2.14)

0.80 (0.40, 1.57)

HPV vaccine will prevent cervical No
cancer

Yes

Having the HPV vaccination

Disagree

might make girls more likely to

Do not know 0.68 (0.53, 0.88)

0.89 (0.58, 1.37)

have sex

Agree

0.55 (0.33, 0.94)

0.56 (0.41, 0.76)

Note: adjusted OR values are estimated based on generalized estimated equation using
identity function (beliefs about HPV vaccine items) or multinomial regression (beliefs
about susceptibility and severity HPV and cervical cancer) after controlling for age,
gender, occupation, religion, marital status, education and awareness about HPV, source
of information about HPV vaccine in the case of beliefs about HPV vaccine items.
School was used as a cluster variable in all the analysis.
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Fig 1. Map of India
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Attitudes and beliefs about HPV infection , cervcal cancer
and HPV vaccine in Mysore, India
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Fig 2. Attitudes and beliefs about HPV infection, cervical cancer and HPV vaccine
among rural (n=831) and urban (n=778) parents of adolescent girls in Mysore district,
India 2010/2011.
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Abstract
Objective: The purpose of this study was to examine factors predicting HPV vaccine
acceptability among parents of adolescent girls in a rural area in Mysore district, India.
Methods: A cross-sectional study was conducted among a random sample of 831 parents
of adolescent girls (ages 11 to 15 years) in villages in Mysore between September and
October, 2011. A questionnaire designed in both English and Kannada was used to
measure factors that can affect parental willingness to vaccinate daughters with HPV
vaccine.
Results: Of the 831 parents participated in this study, 79.9% were willing to vaccinate
their daughter with HPV vaccine sometime soon if they were invited to receive it. Higher
odds of parental willingness to vaccinate their daughters with HPV vaccine was observed
among those who believed that HPV vaccine is safe (Adjusted Odds Ratio [aOR]
2.11;95% CI:1.01, 4.45); daughter may become sexually active (aOR1.84, 95%CI:1.08,
3.13); they have support of other family members to vaccinate their daughter
(aOR2.86,95%CI:1.47,5.57); HPV infection causes severe health
problems(aOR1.64,95%CI:1.04,2.57). On the other hand, parents who believed that there
is low risk that daughter will get cervical cancer(aOR0.52,95%CI:0.29,0.95); family will
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disapprove of getting daughter vaccinated(aOR0.45,95%CI:0.22,0.76); the injection may
cause pain(aOR0.53, 95%CI:0.31,0.89) and were older age parents
(aOR0.96,95%CI:0.93,0.99) had lower odds of willingness to vaccinate daughters with
HPV vaccine.
Conclusions: Acceptance of HPV vaccination for daughters was high among rural
parents in Mysore, India. However, health education to reduce the belief that injection is
painful and daughters are at low risk to get cervical cancer is important to further
improve parental HPV vaccine acceptability in Mysore. The public health education
should target older aged parents and extended family members.
Key words: HPV, vaccine, acceptability, India, Mysore, Parents, Rural
Introduction
Cervical cancer is the second leading cause of cancer death among women in
India (Mishra et al., 2016). Every year, about 122,844 women are diagnosed with the
disease and 67,477 die from it (Mishra et al., 2016). The country ranked first in terms of
the incidence of the disease among south Asian countries in 2012 (Bruni et al., 2016). In
order to effectively control cervical cancer, the Indian Academy of Pediatrics Committee
on Immunization (IAPCOI) approved HPV vaccination for females aged 10-12 years,
who can afford the vaccine, in 2008 (IAPCOI, 2008). Nevertheless, introducing HPV
vaccine in India has had unique challenges due to unconfirmed concerns about the
efficacy and safety of the vaccine (Lamontagne & Sherris, 2013). The death of seven
girls reported during demonstration program in India conducted in 2009 raised several
concerns (Lamontagne & Sherris, 2013). The Indian parliament attributed the deaths to
the HPV vaccine leading to suspension of the demonstration program in 2010 (Larson et
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al., 2010). However, subsequent studies and investigations confirmed that the deaths
were not related to the HPV vaccine (Sachdeva S, Sachdeva R, 2016).
In 2014, the Government of India decided to include HPV vaccine in the National
Immunization Programme (Chatterjee et al., 2016; Vashishtha et al., 2014). The vaccine,
currently, is used by private practitioners in different regions of the country (Sachdeva &
Sachdeva, 2016; WHO, 2017; Science and chronicle, 2017). However, uptake of HPV
vaccination in general has been low due to misperceptions about HPV infection, cervical
cancer and HPV vaccine, and due to cultural reasons in India (Chatterjee et al., 2016;
Madhivanan et al., 2009; Paul et al., 2014; Basu & Mittal, 2011; Madhivanan et al.,
2014). Further investigation of factors that are related to HPV vaccine acceptability
among parents in India may help improve uptake and reduce the burden of cervical
cancer in this country. Identifying factors associated with vaccine acceptance will also
help clinicians and public health advocates to better design evidence-based strategies to
achieve maximum HPV vaccine coverage in the target groups. Much of the research to
date about HPV vaccine acceptability in India has been limited to urban areas with very
limited information being available from rural India where 60% of the Indian population
resides (Madhivanan et al., 2009; Paul et al., 2014; Basu & Mittal, 2011; Madhivanan et
al., 2014). The purpose of this study was therefore to examine factors predicting HPV
vaccine acceptability among parents of adolescent girls in rural India in the south Indian
state of Karnataka.
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Methods
Study setting
Between September and October, 2011, a cross-sectional survey was conducted
among parents of adolescent girls living in villages of Mysore Taluk, in the Indian state
of Karnataka. Karnataka ranks 9th in terms of population (61 million) with the majority of
residents living in rural areas (Census, 2017). The age-standardized cervical cancer
mortality rate in Karnataka was 16.5 per 100,000 in 2010 (Dikshit et al. 2012).
Ethical consideration
This study was conducted after review and approval by the Institutional Review
Boards at Florida International University and Public Health Research Institute of India.
In addition, permission to conduct the study was obtained from the Block Education
officer and school administrators. Parents participated in the study after they provided
written informed consent.
Study participants
A total of 831 parents of adolescent girls (ages 11 to 15 years) attending 7 th
through 10th grades in a cluster of 11 schools located in rural Mysore sub-district were
included in this study. One private and ten government schools were selected from a
group of 43 schools available in the study area based on probability proportionate-to-size
sampling. A program announcement was sent home with all eligible girls (n= 1,725) in
the 11 schools (44 to 137 students from each school), explaining the objective of the
study and inviting parents to participate. Of the 1725, 850 were randomly selected and
provided a questionnaire in Kannada to complete within a week’s time. The number of
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female students needed from each school was determined based on multistage
proportionate-to-size sampling. All (along with assigned number) eligible female students
from each school were enumerated and listed in an excel sheet separately for each school.
Using a computer program, the assigned number of students from each school were
selected using a random sampling technique. Each selected and interested participant was
provided with a questionnaire to take home to their parents, where one parent per
household could complete it and return within seven days along with a signed consent
form. Most parents (97.8%) who received the questionnaire completed the questionnaire
and returned it along with their signed consent form.
Questionnaire and measures
The items included in the questionnaire were adapted from previous studies
(Madhivanan et al., 2009; Witte, 1996; Marlow et al., 2007). The questionnaire was
validated in Kannada (local language in the study area) and has been used in another
study (Madhivanan et al., 2014) before it was used in this study. As some of the parents
living in a rural region were illiterate and may have lacked knowledge about HPV,
cervical cancer and HPV vaccine, we included some basic information in the
questionnaire (Table 1) to enable parents to answer some questions related to attitudes
and beliefs about HPV vaccine and willingness to accept HPV vaccination. The
questionnaire contained 126 items, 59 of which were used to measure psychosocial
factors that have been shown to influence HPV vaccine acceptability in different
countries including India.
[Insert Table 1 here]
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The current study was guided by the conceptual framework of factors that
influence HPV vaccination proposed by Fernandez et al., (2010). Out of 126 items, 59
items representing different constructs that could potentially influence willingness to
vaccinate were selected for the analysis (Fernandez et al., 2010). The constructs included
sociodemographics, awareness about HPV, sources of information about HPV vaccine,
perceived susceptibility to HPV and cervical cancer, perceived severity of HPV and
cervical cancer, perceived facilitators and barriers to vaccination in general and specific
to HPV vaccine, social norms that influence HPV vaccine acceptability, and willingness
to accept HPV vaccine (Fernandez et al., 2010).
Awareness about HPV was assessed by one question (Have you ever heard of
HPV?) with a ‘yes’ or ‘no’ response. Sources of information was assessed using seven
items asking parents where they got information about HPV vaccine (Cronbach’s alpha
[α]= 0.75). Perceived susceptibility, which measures parental attitudes towards
susceptibility of their daughters to getting HPV infection and cervical cancer, was
assessed using four items (α= 0.78). Similarly, perceived severity measured parental
beliefs about severity of HPV infection and cervical cancer using four items (α= 0.73).
Response to all the items that measured perceived susceptibility and severity constructs
were recorded on a three-point scale (1=disagree, 2=do not know, 3=agree). Items that
has a response of ‘Don’t know’ were assumed to be ordinally neutral (Dempsey et al.,
2006).
Questions used to assess parental beliefs and attitudes about HPV vaccine were
grouped into two constructs: perceived facilitators/benefits and perceived barriers to HPV
vaccination. Perceived facilitators were measured using eight items to assess the reasons
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why parents wanted to have their daughter’s HPV vaccination (α=0.67). Similarly,
perceived barriers to HPV vaccination construct was measured using eight items to assess
reasons why parents might not want to have their daughters receive HPV vaccine
(α=0.68). Responses to the 16 items were coded on a three-point scale (1= not important
all, 2=important 3=very important). Likewise, perceived facilitators (α=0.59) and
perceived barriers (α=0.58) to vaccination in general were assessed using six and five
items, respectively. These 11 items were recorded on a three-point scale (1=no, 2=not
sure, 3=yes). Social norms were assessed using seven items (α=0.75) by asking parents
whose opinion such as doctors, spouse, friends, father and mother, other relatives, in-laws
and neighbors might influence their decision in getting their daughter vaccinated.
Responses were recorded on three-point scale (1=no, 2=don’t know, 3=yes). Finally, the
construct for willingness to accept HPV vaccine was assessed by asking parents ‘If your
daughter was invited to get HPV vaccine, would you agree to have it sometime soon’.
Responses were coded on a four-point Likert scale (1= definitely not, 2= probably not, 3=
probably yes, 4= definitely yes). This variable was converted into a dichotomous variable
as acceptors (who responded as ‘probably or definitely’ yes) and non-acceptors (who
responded as ‘probably or definitely’ not) during data analysis (Marlow et al., 2007).
Data analysis
Data were analyzed using Stata software (Version 14, Texas, USA).
Reliability/internal consistency of items forming each construct, was assessed using
Cronbach’s alpha. The outcome variable was ‘HPV vaccine acceptability’. The calculated
internal reliabilities (Cronbach’s α) for the items forming the constructs were substantial
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or moderate. Thus, a composite score was developed by adding values of responses to the
items that form each of the construct (Fernandez et al., 2010).
Percentages were used to describe the demographic status and the frequency of
responses of parents to the questions addressing willingness to receive HPV vaccine, as
well as beliefs and attitudes about HPV infection, cervical cancer and HPV vaccine. Chisquare tests were performed to check whether parental intention to accept HPV vaccine
for their daughter was related to demographic characteristics, as well as beliefs and
attitudes of parents about HPV, cervical cancer, and HPV vaccine. Multiple logistic
regression was used to assess factors associated with HPV vaccine acceptance. To
account for potential clustering of HPV acceptance by the school that the daughters
attended, analysis was performed using the Generalized Estimating Equations (GEE) in
Stata using the xtgee command. Estimated within-school correlation matrix value for
HPV vaccine acceptability was 0.0078. While fitting the regression models, factors that
were included in the regression model were checked for multicollinearity. As there were
missing values for some of the items (Missing range: 0.48 to 3.61%) included in the
regression model, a multiple imputation method (using chained equation) based on 20
iterations was used to estimate the missing values before fitting the GEE (Azur et al.,
2011).
Results
Of the 850 parents who were contacted, 831 agreed to participate and returned the
completed questionnaire within seven days. The mean age of the parents was 37.1± 6.67
years. Almost all study participants were Hindu by religion (99.0%) and married (91.5%).
Most respondents were mothers (76.8%), working part-time (43.0%) and lacked formal
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education (63.4%). Most had heard about HPV (75.4%). Majority of the parents got
information about HPV vaccines from their daughter's school (86.6%), doctor (83.6%),
television (76.2%), Auxillary Nurse Midwife or anganwadi teacher (72.0%). Of the 831
parents, 79.9% (Yes probably=30.2%, Yes definitely=49.7%) were willing to vaccinate
their daughter with HPV vaccine sometime soon if they were offered the vaccine for their
daughter (Table 2). When compared to mothers, fathers were more likely to be educated
(55.4% vs 30.9%), employed (92.2% vs 46.2%), and older than 35 years of age (87.6% vs
34.3%). However, the proportion of parents who were Hindus, married, and were willing
to vaccinate their daughter with HPV vaccine were similar between fathers (99.5%,
94.3% and 77.7%, respectively) and mothers (98.9%, 90.6% and 80.6%, respectively).
[Insert Table 2 here]
Parents who were willing to vaccinate their daughter with HPV vaccine reported
the following characters as main reasons for their willingness: recommendation from
doctor or nurse (96.2%), belief that HPV vaccine will prevent cervical cancer (92.8%),
belief that HPV vaccine is safe (92.0%), having support from other family members to
vaccinate daughter with HPV vaccine (89.5%), and learning more about the relationship
of HPV to cervical cancer (89.2%) (Table 3).
Among parents who refused to vaccinate their daughter with HPV vaccine, the
most frequent reasons for refusal were, being worried about safety of the vaccine
(67.1%), the perception that the vaccination may not be effective (67.1%), that injection
may cause pain (65.9%) and their perception that their daughter is at low risk of
becoming infected with HPV infection (65.9%). Willingness to receive HPV vaccine was
also lower among parents who were afraid of vaccinations in general.
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[Insert Table 3 here]
Based on multiple regression analysis, the odds ratio of willingness to vaccinate
was positively associated with the perceived benefits of HPV vaccination (aOR 1.16,
95%CI: 1.07, 1.25). The odds ratio of willingness to vaccinate was particularly greater
among parents who believed that the vaccine was safe (aOR 2.11; 95%CI: 1.01, 4.45);
daughter may become sexually active (aOR 1.84, 95%CI: 1.08, 3.13); and they have
support from other family members to vaccinate their daughter (aOR 2.86, 95%CI: 1.47,
5.57). Willingness to vaccinate their daughter with HPV vaccination was also greater
among parents who believed that vaccination was one way that parents could ensure their
child’s health (aOR 10.75, 95%CI: 3.04, 38.0), and among those who believed that HPV
infection could cause severe health problems (aOR 1.64, 95%CI: 1.04, 2.57). Parents
with 1 to 10 years of education were more willing to vaccinate their daughter as
compared to parents who lacked any education (1.92, 95%CI: 1.13, 3.26) (Table 4).
On the other hand, the odds ratio of willingness to vaccinate was negatively
associated with the perceived barriers of HPV vaccination (aOR 0.92, 95%CI: 0.87,
0.99). The odds were particularly lower among parents who believed that their daughter
was at low risk to get cervical cancer (aOR 0.52, 95%CI: 0.29, 0.95); the family may
disapprove of getting their daughter vaccinated (aOR 0.45, 95%CI: 0.22, 0.76) and the
injection may cause pain (aOR 0.53, 95%CI: 0.31, 0.89). Parental willingness to
vaccinate their daughter also decreased with increasing age of the parent (aOR 0.96,
95%CI: 0.93, 0.99) (table 3).
[Insert Table 4 here]
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Discussion
The purpose of this study was to examine facilitators and barriers to parental
acceptability of HPV vaccine for adolescent girls in rural Mysore, India. The majority of
the parents (79.9%) were willing to vaccinate their daughter with HPV vaccine. The
main factors associated with HPV vaccine acceptance were parental education, the belief
that the vaccine was safe and HPV infection could cause severe health problems,
daughter might become sexually active, having support of other family members to
vaccinate daughter, and believing that vaccination is one way to ensure their child’s
health. On the contrary, low risk perception that daughter will get cervical cancer, fear
that other family members might disapprove of getting daughter vaccinated, injection
may cause pain, and increasing age of the parent were all associated with not intending to
accept HPV vaccination for their daughter.
There was a higher rate of HPV vaccine acceptance in this population as
compared to that reported among parents in the other regions of India (Range: 46% to
74%) (Basu & Mittal, 2011; Madhivanan et al., 2014; Montgomery et al., 2015) and other
countries in south Asia (Range: 26.5% to 84.0%) (Sam et al., 2009; Charakorn et al.,
2011; Yu et al., 2016; Wang et al., 2015). Even within the same district, vaccine
acceptance in this rural study population was greater than among parents living in the
urban region (71.1%) (Madhivanan et al., 2014). This increased rate of HPV vaccine
acceptance in the current study could be due to better awareness about cervical cancer
and HPV vaccine, or due to a more positive attitude towards vaccinations in general and
the immunization programs run by the government. Indeed, a study reported higher levels
of knowledge about general issues related to vaccination among parents who lived in
48

rural than urban areas of the same district, where the current study was conducted
(Madhivanan et al., 2009). The level of awareness about HPV in Senegal was also greater
among adolescents and parents who were living in rural area than the urban ones (Massey
et al., 2017). The National Rural Health Mission that was started in 2005 by the
government of India to improve maternal child health outcomes in rural India has focused
on improving immunization coverage at the village level in rural India. This initiative
may have also helped increase knowledge, sensitize the rural residents about the
importance of immunization in general and helped develop positive attitudes towards
vaccination among rural parents in this area.
The perception that their daughters were at low risk to get cervical cancer, pain
associated with injection, and disapproval by other family members for vaccinating
daughters were significant predictors of low parental acceptability HPV vaccine for their
daughters. A study among urban parents in the same district also reported association of
the belief that injection may cause pain with a lower odds of HPV vaccine acceptance
(Madhivanan et al., 2014). Parental beliefs that daughter may be at low risk of getting
cervical cancer could be due to lack of knowledge that HPV infection is a cause for
cervical cancer (Chatterjee et al., 2016). Disapproval of other family members to get
daughter vaccinated may be due to lack of awareness that adolescents are susceptible to
HPV infection (Burd, 2003). To reduce these barriers and promote HPV vaccination of
girls in this area in the future, public health education programs for parents must focus on
the transmission mechanisms of HPV infection, cancers caused by HPV infection (e.g.
cervical cancer), and the fact that cervical cancer can be prevented by HPV vaccination
(Hager, 2009; Haugsdal & Ryan, 2015; Roussos-Ross et al., 2017; Tyson et al., 2017;
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Yudin, 2010). Scope of this education should be broadened to include extended family
members as they have a large influence on parental decision making to recommend HPV
vaccination for girls in the community.
Another barrier to HPV vaccine acceptability in this study was the older age of
the parent. This finding is consistent with a previous report from Indonesia, which
showed lower HPV vaccine acceptance among older age parents compared to the
younger ones (Jaspers et al., 2011). A study in Thailand also showed lower acceptability
of HPV vaccine for daughters among parents older than 45 years compared to those
younger than 45 (Charakorn et al., 2011). More positive attitudes among younger parents
could be due to changing sexual norms, access to information as compared to older age
parents who may be less interested in health information related to sexually transmitted
infection. In addition, older age parents may have negative beliefs about HPV vaccine
due to previous experiences with and beliefs about vaccinations in general (side effects).
Further research should focus on understanding the information needs of older parents to
improve HPV vaccine acceptability in rural India.
A strength of this study was the focus on rural population—a population that has
not been studied adequately. In addition, this study included a relatively large probability
sample based on weighted random sampling methods. Almost all of the study participants
contacted participated in this study as the population was interested and so few groups or
organizations are interested in getting the opinion and understanding the needs of rural
residents in this region. However, the study was not without limitations. Only parents of
school going adolescent girls were included in this study. This would limit
generalizability of the findings to parents who do not have school going children within
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that age group. Furthermore, due to variations in social practices, culture, religion and
economic composition, all of which may affect individual beliefs about HPV, cervical
cancer and HPV vaccine, the current study findings may not be generalizable to parents
in other regions of India. The fact that only eight parents were Muslims in the current
study may also limit generalizability of the results to other religions since the majority of
the sample belonged to Hindu religion. Most of the Muslims in Mysore districts are
concentrated in urban areas with very small percent living in rural regions. However,
Muslims form a sizable portion of the overall population in India (Census, 2017). In
addition, as the data were self-reported, some parents, especially the illiterate ones, may
have received support from friends or extended family members while responding to
some questions which may have caused information bias. Moreover, although provision
of information about cervical cancer prevention methods, HPV and HPV vaccine enabled
illiterate parents or those who lacked knowledge to answer some questions related to
attitudes and beliefs about cervical cancer, HPV and HPV vaccine, this might have also
overestimated the strength of association between HPV vaccine acceptability and
attitudes about HPV, cervical cancer and HPV vaccine in this sample. Moreover, there
were missing data for some questions, which might lead to a biased estimation of the
observed association between parental beliefs and attitudes about HPV vaccine and
cervical cancer with HPV vaccine acceptance. However, the multiple imputation method
used to predict the missing values showed results that were comparable to those obtained
with analysis with complete dataset after removing the missing values. There was a very
minor difference in the magnitude of the odds ratio, standard errors and 95% CI
estimates. The current study assessed parents willingness to vaccinate their daughter with
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HPV vaccine. Hence, we cannot be sure if parents would actually vaccinate their
daughter if the vaccine were offered. According to the conceptual framework proposed
by Fernandez which guided this study, the nature of the environment will further modify
the influence of parent’s willingness to vaccinate daughter with HPV vaccine on the
actual uptake of HPV vaccine (Fernandez et al., 2010). Finally, the study was conducted
between September and October, 2011. There may have been changes in the beliefs and
attitudes of parents regarding HPV infection, cervical cancer and HPV vaccine in the last
seven years. This time delay in the conduct and the presentation of the study results may
influence the nature of policy measures that can be designed to increase HPV vaccine
acceptability among rural parents in Mysore, India.
Conclusions
In conclusion, this study is one of few studies that addresses public health issues
among rural Indians. Willingness to vaccinate daughters with HPV vaccine was high
among rural parents in Mysore district. However, public health education programs to
reduce the false perception of low risk of getting cervical cancer, and fear of pain with
injection will be important issues to focus among parents in Karnataka to reduce cervical
cancer rates and further improve parental acceptability of HPV vaccine in the district.
Health education programs should target older aged parents as well as extended family
members to ensure increased vaccination uptake in the future in rural India.
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Table 1. HPV, cervical cancer and HPV vaccine information presented to the
participants in Mysore, India, 2011
What is cervical cancer?
 Cervical cancer is a disease which affects the entrance to the uterus
(womb). It is the result of uncontrolled growth of abnormal cells which
eventually form a lump or tumour
 If cervical cancer is not detected and treated early, it can lead to serious
health consequences including death.
What causes cervical cancer?
 Scientists have linked most cases of cervical cancer to a common virus
called human papillomavirus or HPV
How is HPV related to cervical cancer?
 There are over 100 HPV virus types but only about 15 that cause cancer.
The two most common types, 16 and 18, are responsible for most cases
of cervical cancer
 HPV infection that causes cervical cancer has no symptoms.
 Women who develop cervical cancer are usually unaware of their HPV
infection
 While HPV may clear up on its own without treatment, some women
are unable to rid themselves of the infection. Often, these women are at
higher risk for cervical cancer
 When an HPV infection persists, it can cause cell changes which
eventually lead to cervical cancer if left untreated
 HPV can also cause genital warts, small lumps or growths on the
genitals. While these are unrelated to cervical cancer and are generally
not dangerous, they can be prevented through vaccination
How does HPV Cause Cervical Cancer?
 HPV is generally spread through sexual contact. In India, most women
acquire the infection when they marry.
 Sexual intercourse is not required to spread an HPV infection. The virus
easily travels from person to person by skin-to-skin contact alone
 HPV causes cancer through a slow process. If a woman is unable to
clear the infection, the cells in her cervix gradually change. If these
abnormal cells are not detected and treated, they can become a
cancerous tumour
What is the HPV vaccine?
 A vaccination has now been developed that will protect women against
infection with HPV
 The vaccination will help prevent cervical cancer
 It will also protect against genital warts
 Trials of the vaccination have shown it to be 99% effective in protecting
against infection with the most common cancer-causing HPV viruses
 The vaccination must be given to girls before they become sexually
active, in order to get full protection
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Table 2. Sociodemographic characteristics of participants and HPV vaccine acceptability
in Mysore, India, 2011 (N=831)

Total
Sex
Age in years

Education

Occupation

Marital Status
Religion
Have you ever
heard about
HPV?

Male
Female
≤35
36-40
41-50
>50
No formal education
Grade 1 to 10th
More than 10th grade
Retired/unemployed
Full-time homemaker
Self-employed
Employed part-time
Employed full-time

193
638
443
228
129
31
527
285
19
11
347
58
357
58
71
760
823
8
204
627

Separated/widowed

Married
Hindus
Muslim
No
Yes
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Percent of willing p-value
to vaccinate
77.7
80.6
0.388
81.5
0.125
80.3
77.5
64.5
76.1
0.006
86.3
89.5
72.7
0.030
82.1
87.9
75.4
87.9
78.9
0.821
80.0
80.0
0.728
75.0
83.3
0.159
78.8

Table 3. Attitudes and beliefs about HPV, cervical cancer and vaccination and HPV
vaccine acceptability in Mysore, India, 2011 (N=831)

Total Percent willing p-value
to vaccinate
Susceptibility to HPV or cervical cancer
My daughter may be at risk of getting
Disagree
HPV infection
Do not know
Agree
It is likely that my daughter may get
Disagree
HPV infection in the future
Do not know
Agree
It is possible that my daughter will get Disagree
cervical cancer in the future
Do not know
Agree
It is likely that my daughter may get
Disagree
cervical cancer someday
Do not know
Agree
Severity of HPV or cervical cancer
I believe that HPV infection can cause Disagree
serious health problem
Do not know
Agree
I believe that HPV infection can be
Disagree
extremely harmful.
Do not know
Agree
I believe that cervical cancer is a serious Disagree
disease
Do not know
Agree
I believe that cervical cancer can be
Disagree
extremely harmful.
Do not know
Agree
Perceived facilitators to HPV vaccination
Recommendation from doctor or nurse No
Yes
Worry about daughter getting cervical
No
cancer
Yes
Believe that HPV vaccine is safe
No
Yes
Worry that daughter may become
No
sexually active
Yes
Support from family members to
No
vaccinate your daughter
Yes
Knowing more about the relationship of No
HPV to cervical cancer
Yes
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194
523
114
172
538
121
175
555
101
184
531
116

76.8
80.5
82.5
77.3
79.4
86.0
76.6
81.4
77.2
77.2
81.0
79.3

0.419

74
283
474
84
226
521
90
245
496
73
523
235

70.3
73.1
85.4
64.3
71.2
86.2
68.9
73.9
84.9
65.8
84.7
73.6

<0.001

40
787
346
470
68
740
379
403
107
716
103
722

57.5
81.2
77.5
81.3
54.4
82.6
76.0
83.4
59.8
82.9
64.1
82.0

0.168

0.290

0.532

<0.001

<0.001

<0.001

<0.001
0.180
<0.001
0.01
<0.001
<0.001

Government approval of vaccine

No
Yes
Belief that vaccine will prevent cervical No
cancer
Yes
Perceived facilitators to vaccination in general
Vaccinations are effective in preventing No
disease
Not sure
Yes
It is very important that my daughter
No
receive all her vaccinations
Not sure
Yes
Vaccination is one way that parents can No
ensure their child health
Not sure
Yes
I have a responsibility to have my
No
children vaccinated for the protection of Not sure
all children.
Yes
The government does a good job
No
providing vaccine and health services
Not sure
Yes
I would feel responsible if anything bad No
happened I did not my child vaccinated Not sure
Yes
Perceived barriers to HPV vaccination
High cost of the vaccine
No
Yes
Low risk that daughter will be infected No
with HPV
Yes
Low risk that daughter will get cervical No
cancer
Yes
Family will disapproval of getting
No
daughter vaccinated
Yes
Injection may cause pain
No
Yes
Not enough information available about No
HPV vaccine
Yes
Worried about safety of the vaccine
No
Yes
Vaccination may not be effective
No
Yes
Perceived barriers to vaccination in general
I would feel responsible if anything bad No
happened I had my child vaccinated
Not sure
Yes
I am concerned about side effects of
No
vaccinations
Not sure
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117
698
77
748

67.5
81.8
57.1
82.3

123
168
515
15
42
767
23
64
732
17
27
770
33
75
708
105
97
600

72.4
78.6
82.5
53.3
66.7
81.4
39.1
59.4
83.5
76.5
55.6
81.2
84.8
68.0
81.5
76.2
71.1
83.7

281
544
230
590
255
562
383
430
360
459
253
563
228
591
257
569

75.8
81.8
75.2
81.4
78.8
80.3
83.0
77.4
85.0
76.0
75.1
82.2
77.1
81.0
78.6
80.3

226
133
442
314
189

77.9
84.2
81.9
79.9
80.4

<0.001
<0.001

0.034
0.002

<0.001
0.004

0.016

<0.005

0.042
0.050
0.638
0.047
0.001
0.018
0.131
0.569

0.278

0.811

Yes
299
81.9
I am afraid of vaccinating my children No
521
83.7
Not sure
63
57.1
Yes
238
78.2
It is better to get the disease and get
No
158
87.3
protected naturally than vaccinated
Not sure
92
75.0
Yes
563
78.9
There are too many vaccines already
No
83
59.0
included in childhood vaccine schedule Not sure
180
80.6
Yes
556
82.9
***Numbers for some items do not add up to 831 due to missing data
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<0.001

0.027

<0.001

Table 4. Facilitators and barriers to accept HPV vaccination among 831 rural parents in Mysore in Mysore, India, 2011
Variables
Sociodemographic factors
Sex
Age
Education
Occupation
Marital Status
Religion
Awareness about HPV (Have you ever heard about HPV?)
Susceptibility to HPV and cervical cancer
HPV
Cervical cancer
Severity of HPV and cervical cancer
HPV
Cervical cancer
Perceived facilitators to HPV vaccination
Recommendation from doctor or nurse
Worry about daughter getting cervical cancer
Belief that HPV vaccine is safe
Worry that daughter may become sexually active
Support from family members to vaccinate your daughter
Knowing about the relationship of HPV to cervical cancer
Government approval of vaccine
Belief that vaccine will prevent cervical cancer
Perceived facilitators to vaccination in general
Vaccinations are effective in preventing disease
It is very important that my daughter receive all her
vaccinations

Categories

Female
Continuous
Grade1 to 10th
≥High school
Employed
Married
Muslims
Yes
Continuous
Continuous
Continuous
Continuous
Continuous
Continuous
Continuous
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Continuous
Ye
Yes
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Unadjusted OR
(95% CI)

Adjusted OR
(95% CI)

1.17 (0.78, 1.73)
0.98 (0.95, 1.00)
1.95 (1.32, 2.90)
2.59 (0.59, 11.26)
0.81 (0.57, 1.15)
1.05 (0.58, 1.92)
0.71 (0.14, 3.47)
1.33 (0.88, 2.03)
1.06 (0.97, 1.16)*
1.33 (0.95, 1.85)
1.08 (0.77, 1.51)
1.31 (1.20, 1.42)*
2.42 (1.80, 3.24)
2.09 (1.58, 2.77 )
1.17 (1.10, 1.24)*
3.20 (1.67, 6.14)
1.23 (0.88, 1.74 )
3.96 (2.37, 6.63)
1.27 (1.01, 1.59)
3.21 (2.08, 4.95 )
2.54 (1.62, 3.96)
2.23 (1.44, 3.44)
3.49 (2.14, 5.69)
1.26 (1.13,1.40)*
1.85 (1.17, 2.93)
4.00 (1.43, 11.20 )

1.11 (0.59, 2.10)
0.96 (0.93, 0.99)
1.92 (1.13, 3.26)
2.09 (0.36, 12.11)
1.17 (0.71, 1.92)
0.48 (0.21, 1.11)
0.68 (.09, 5.02)
1.22 (0.70, 2.10)
0.99 (0.89, 1.10)*
1.50 (.86, 2.61)
0.90 (0.52, 1.56)
1.21 (1.10, 1.33)*
1.64 (1.04, 2.57)
1.16 (0.73, 1.83)
1.16 (1.07, 1.25)*
1.07 (0.41, 2.79)
0.82 (0.48, 1.39)
2.11 (1.01, 4.45)
1.84 (1.08, 3.13)
2.86 (1.47, 5.57)
0.92 (0.44, 1.95)
0.94 (0.49, 1.80)
1.57 (0.73, 3.36)
1.09 (0.95, 1.25)*
1.01 (0.51, 2.00)
1.63 (0.28, 9.35)

Vaccination is one way that parents can ensure their child
health
I have a responsibility to have my children vaccinated for the
protection of all children
The government does a good job providing vaccine and
health services
I would feel responsible if anything bad happened I did not
have my child vaccinated
Perceived barriers to HPV vaccination
High cost of the vaccine
Low risk that daughter will be infected with HPV
Low risk that daughter will get cervical cancer
Family will disapproval of getting daughter vaccinated
Injection may cause pain
Not enough information available about HPV vaccine
Worried about safety of the vaccine
Vaccination may not be effective
Perceived barriers to vaccination in general
I would feel responsible if anything bad happened I had my
child vaccinated
I am concerned about side effects of vaccinations
I am afraid of vaccinating my children
It is better to get the disease and get protected naturally than
vaccinated
There are too many vaccines already included in childhood
vaccine schedule
Do you know someone with cervical cancer?
Social norms
Do you think the following people would want you to
vaccinate your daughter against HPV infection
Your Doctors
Your spouse
Your friends

Yes

7.56 (3.22, 17.74) 10.75 (3.04, 38.0)

Yes

1.76 (0.62, 4.98)

0.33 (0.05, 2.08)

Yes

0.88 (0.33, 2.39)

0.31 (0.07, 1.32)

Yes

1.67 (1.02, 2.75 )

1.04 (0.50, 2.15)

Continuous
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Continuous
Yes

0.99 (0.95, 1.04)*
1.40 (0.98, 1.98)
1.43 (0.99, 2.07)
1.07 (0.74, 1.53)
0.68 (0.48, 0 .97)
0.57 (0.40, 0.82)
1.51 (1.05, 2.16)
1.29 (0.89, 1.86)
0.91 (0.63, 1.31)
0.97 (0.89, 1.07)*
1.27 (0.85, 1.88 )

0.92 (0.87, 0.99)*
1.77 (1.06, 2.96)
1.17 (0.64, 2.14)
0.52 (0.29, 0.95)
0.45 (0.26, 0.76)
0.53 (0.31, 0.89)
1.86 (1.09, 3.18)
0.87 (0.49, 1.54)
1.00 (0.57, 1.77)
0.99 (0.89, 1.10)*
1.05 (0.58, 1.89)

Yes
Yes
Yes

1.09 (0.72, 1.66)
0.68 (0.46, 1.01)
0.56 (0.33, 0.93)

0.95 (0.55, 1.66)
0.77 (0.44, 1.35)
1.05 (0.54, 2.04)

Yes

3.37 (2.06, 5.49)

1.90 (0.94, 3.84)

Yes
Continuous

0.65 (0.36, 1.15) 0.61 (0.27, 1.38)
1.03 (0.99, 1.07)* 1.01 (0.97, 1.04)*

Yes
Yes
Yes

1.94(1.23, 3.07)
2.14 (1.42, 3.24)
1.19 (0.77, 1.83)
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1.55 (0.83, 2.92)
2.25 (1.22, 4.12 )
1.06 (0.53, 2.09)

Your father & mother
Other relatives
Your in-laws
Your neighbors
Source of information about HPV vaccine
Television
Newspaper or Radio
Internet
Doctor
ANM or Anganwadi teacher or Worker
Friends or Neighbours
My daughter's school
Family member or relatives
Recommended age for HPV vaccination

Yes
Yes
Yes
Yes
Continuous
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Continuous

1.77 (1.14, 2.74)
0.72 (0.48, 1.10)
1.33 (0.89, 1.98)
0.87 (0.54, 1.40)
1.09 (1.00, 1.18)*
1.96 (1.32, 2.92)
1.26 (0.86, 1.85)
1.07 (0.76, 1.52)
2.07 (1.29, 3.30)
1.14 (0.74, 1.77)
1.20 (0.83, 1.73)
0.80 (0.38, 1.67)
1.25 (0.87, 1.80)
1.13 (0.96, 1.35)

0.84 (0.44, 1.64)
0.44 (0.20, 0.94)
1.48 (0.76, 2.88)
0.78 (0.35, 1.74)
1.05 (0.95, 1.16)*
1.16 (0.57, 2.38 )
0.78 (0.41, 1.51)
1.49 (0.89, 2.50)
1.50 (0.70, 3.19)
0.53 (0.27, 1.03)
0.71 (0.38, 1.31)
0.90 (0.35, 2.31)
1.80 (0.94, 3.45 )
1.10 (0.88, 1.38)

*Odds ratio estimates are based on a GEE that included constructs with composite scores estimated based on the sum of scores of individual items that
formed the constructs.
Reference for ‘yes’ categories are ‘no’
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Abstract
Objective: The study examined factors that directly affect, mediate, and moderate
parental intention-to-vaccinate adolescent daughters with HPV vaccine in Mysore
district, India.
Methods: A cross-sectional study was conducted among 1,609 parents of adolescent girls
attending schools in Mysore between February 2010 and October 2011. A validated
questionnaire was used to assess parental attitudes and beliefs related with HPV
infection, cervical cancer, HPV vaccine and vaccination. Structural equation modeling
was used to estimate parameters and assess whether a model based on the integrative
behavior theory would fit the current data.
Results: More than two-thirds (78.0%) of parents would accept vaccinating their
daughters with HPV vaccine. HPV vaccine acceptance significantly increased with an
increase in the perception of parents about the benefits (standardized regression
coefficient (β) = 0.39) or sources of information about HPV vaccine (β = 0.24), but the
rate decreased significantly with an increase in the perception about barriers to HPV
vaccination β = -0.44). The effect of beliefs about severity of HPV infection or cervical
cancer (β = 0.20), and beliefs about benefits (β = 0.20) or barriers (β = -0.25) to
vaccination in general on HPV vaccine acceptance were significantly mediated by
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parental attitudes or source of information about HPV vaccine. Geographical living area
significantly moderated the effect of awareness about HPV on beliefs about severity of
HPV infection or cervical cancer (β = 0.33), and the effect of religion on norms related to
HPV vaccination (β = 0.19).
Conclusions: This study identified modifiable parental attitudes about HPV vaccine and
beliefs related with HPV infection, cervical cancer and vaccination, which predicted
parental intention-to-vaccinate their adolescent daughters with HPV vaccine in Mysore
district, India. Health education interventions tailored to counter parental negative
attitudes and beliefs about HPV vaccine and vaccination in general would be important
for the Indian community to promote HPV vaccination.
Keywords: HPV vaccine, Acceptability, Daughter, Parent, India

Introduction
About 67,477 women in India die every year due to cervical cancer (Mishra et al.
2016). Identifying and treating precancerous lesions would greatly reduce the incidence
of invasive cervical cancer in the country (Saxena et al., 2012; Bobdey et al., 2016).
However, due to shortage of infrastructure and trained experts, organized populationbased cervical cancer screening programs are practically non-existent in India at present
(Mishra et al., 2016; Chatterjee et al., 2016). Primary prevention practices such as
vaccination are important to effectively reduce the incidence of cervical cancer in the
country.
The Indian government approved Human Papillomavirus (HPV) vaccination for
females aged 10 to 12 years in 2008 (IAPCOI, 2008). However, HPV vaccination in
India was suspended in 2010 due to the death of seven girls during a clinical trial in the
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country conducted from 2009 to 2011 by the Programme for Appropriate Technology in
Health, the Indian Council of Medical Research, and the state governments of Andhra
Pradesh and Gujarat. The aim of the clinical trial was to study the appropriate delivery
strategy and feasibility of HPV vaccine to prevent HPV infection among girls
(Lamontagne & Sherris, 2013). A few years later, the Indian government received $500
million in aid from Global Alliance for Vaccines and Immunization, to roll out different
vaccines, including HPV vaccine (Indian Express, 2018). As a result, the Ministry of
Health in the country ordered the Immunization Technical Advisory Committee to check
the safety and efficacy of the HPV vaccine in order to determine whether to include the
vaccine in the immunization programme, at least on a pilot basis (Asian Age, 2018). In
2015, HPV vaccine was approved to be included in the National Immunization
Programme by the Government of India (Vashishtha et al., 2014; Chatterjee et al., 2016;
Indian Express, 2018). In 2016, the states of Punjab and New Delhi included HPV
vaccination in their immunization/public health programme (Sabeena et al., 2018). To
date, due to some controversies by the government officials (Das, 2018), HPV vaccine
was partially introduced in the Immunization Programme for eligible girls in India
(WHO, 2018). However, the vaccine is commercially available at a subsidized cost, for
eligible girls in most regions of the country in two (if the first dose is taken before the age
of 15) or three (if the first dose is taken at or after the age of 15 years or among
immunocompromised girls) doses over a six to 12-month period (Arora, 2017; Sabeena et
al., 2018).
When the HPV vaccine is fully included in the Immunization Program in India,
uptake of the vaccine among eligible girls might be low due to misperceptions about
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HPV infection, cervical cancer and HPV vaccine, or vaccination in general (Basu et al.,
2011; Paul et al., 2014; Montgomery et al., 2015; Santhanes et al., 2018). Lower intention
to HPV vaccination was associated with parental negative beliefs about HPV vaccine
(e.g. side effects, high cost, less efficacious, promote sexual promiscuity) in India (Basu
et al., 2011; Paul et al., 2014; Montgomery et al., 2015), Indonesia (Jaspers et al., 2011),
Thailand (Charakorn et al., 2011), Japan (Hanley et al., 2012) and Malaysia (Sam et al.,
2009). Studies also showed a decreased intention to vaccinate daughters with HPV
vaccine among parents who had poor perception of susceptibility to HPV infection or
cervical cancer, and severity of the disease in India (Montgomery et al., 2015), Indonesia
(Grandah et al., 2018), Japan (Hanley et al., 2012) and Thailand (Grandah et al., 2018;
Juntasopeepun & Thana, 2018).
Studies among parents in urban and rural regions in Mysore district, India also
showed an association of parental attitudes and beliefs about HPV infection, cervical
cancer and HPV vaccine with their intention-to-vaccinate daughters with HPV vaccine
(Madhivanan et al., 2009; Madhivanan et al., 2014; Degarege et al., 2018). However, of
the three previously published articles on intention to HPV vaccination in Mysore district
(Madhivanan et al., 2009; Madhivanan et al., 2014; Degarege et al., 2018), one was
qualitative (Madhivanan et al., 2009), and two quantitative studies assessed factors
associated with HPV vaccine acceptance among parents in urban (Madhivanan et al.,
2014) and rural (Degarege et al., 2018) regions by examining items used to measure the
constructs related to HPV infection, cervical cancer and HPV vaccine in the models
independently, but not as a group. In addition, analysis of the factors associated with
HPV vaccine acceptance in the previously published quantitative studies in Mysore
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district (Madhivanan et al., 2014; Degarege et al., 2018) was conducted using generalized
estimated equations following the conceptual model proposed by Fernandez et al. (2010).
Fernandez et al. (2010) proposed that sociodemographic factors, attitudes, and beliefs
related with HPV infection, cervical cancer and HPV vaccine are all immediate
antecedents of HPV vaccine acceptance. However, the Integrated Behavior Theory (IBT)
and theory of planned behavior suggests that attitudes, norms and self-efficacy affect
intention to practice a behavior directly, but the effect of belief factors on intention to
practice a behavior is indirect through attitudes and norms (Montaño & Kasprzyk, 2008;
Fishbein, 2000). In turn, sociodemographics, knowledge, and personality traits indirectly
influence attitudes, subjective norms, and self-efficacy by affecting belief factors. The
IBT synthesizes the constructs of knowledge, beliefs, attitudes, norms, self-efficacy,
environmental constraints and intention from the theory of reasoned action, theory of
planned behavior, social cognition theory and health belief theory to effectively explain
factors that influence preventive health behavior particularly vaccination (Montaño &
Kasprzyk, 2008; Fishbein, 2000). Due to the complex and overlapping nature of the
factors that could affect preventive health behavior, models that follow an integrative
approach will be more appropriate to examine determinants/antecedents to preventive
health behavior. However, most studies in India examined factors associated with HPV
vaccine acceptance after including sociodemographic factors, attitudes, and beliefs
related with HPV infection, cervical cancer and HPV vaccine in a logistic regression
model as direct predictors of HPV vaccine acceptance (Basu et al., 2011; Paul et al.,
2014; Montgomery et al., 2015; Madhivanan et al., 2014; Degarege et al., 2018). In
addition, most of these studies were conducted in urban areas of India (Basu et al., 2011;
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Paul et al., 2014; Montgomery et al., 2015; Madhivanan et al., 2014). Thus, the current
study analyzed data from urban (Madhivanan et al., 2014) and rural regions (Degarege et
al., 2018) following an IBT-derived model using a more robust analytic technique (i.e.
structural equation modeling) to better understand parental HPV vaccine acceptance in
Mysore, India.
Identifying factors that are related to HPV vaccine acceptance among parents in
India will help guide the development of the contents and delivery mechanisms of health
education programs to achieve maximum HPV vaccine coverage among the target
population in Mysore. Results from this study could also be used to design evidencebased health education programs to increase HPV vaccine acceptance in other areas of
India as well as other South Asian countries after modifying/adjusting to the context of
culture, religion and sociodemographic status of the population in the country. The
current study aimed to assess: i) direct and indirect predictors of HPV acceptance; ii)
moderating effects of area of living on the relationship between socioeconomic status and
indirect predictors of HPV acceptance; and iii) appropriateness of a model based on the
IBT to fit the current data.
Methods
Study setting
A survey was conducted among parents in urban and rural areas in Mysore
district, India. The survey in the urban area was done between February 2010 and January
2011 and the survey in the rural area was conducted between September and October
2011. In 2010, cervical cancer mortality rate was 16.5 per 100,000 in Karnataka (Dikshit
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et al., 2012). Mysore district is the third (out of 30) most populous (3,001,127, density=
450/km2) administrative district located in the southern part of Karnataka (Census,
2011). Greater proportion of the inhabitants (1,755,714) in Mysore district live in rural
areas (Census, 2011).
Ethical consideration
This study was conducted after ethical approvals were obtained from the
Institution Review Boards at Florida International University and Public Health Research
Institute of India. Block Education officer and school administrators in the relevant
villages also granted permission to conduct the study, and written informed consent was
obtained from parents who participated in this study.
Study design and participants
This study was cross-sectional in design and the study participants were parents
who had daughter(s) aged 11 to 15 years attending 7th through 10th grades. A total of 778
parents living in the urban area and 831 parents living in the rural areas of Mysore district
participated in this study. Detailed description of the study procedures are available
elsewhere (Degarege et al., 2018). In brief, 12 schools located in the urban area and 11
schools located in the rural area were selected based on probability proportionate-to-size
sampling. Second, all eligible girls in the selected schools were given a program
announcement that explained the study and invited parents to participate. Then 800 girls
attending schools located in the urban area and 850 girls attending schools located in the
rural area of the Mysore district were randomly selected and provided with a
questionnaire and consent form to be completed by the parents. The questionnaire was
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completed by one parent in a family. Majority of the parents in both the urban (97.3%)
and rural (97.8%) areas returned the completed questionnaires and signed consent forms.
Measures
Health behavior theories appropriate for examining HPV vaccine acceptability
and studies that reported factors related to HPV vaccine acceptance were referred to
while developing the questionnaire used in this study (Madhivanan et al., 2009; Montaño
& Kasprzyk, 2008; Fishbein, 2000; Marlow et al., 2007). The items in the questionnaire
were grouped into eight constructs (beliefs about susceptibility to HPV infection or
cervical cancer, beliefs about severity of HPV infection or cervical cancer, beliefs about
benefits of vaccination, beliefs about barriers to vaccination, attitudes about benefits of
HPV vaccination, attitudes about barriers to HPV vaccination, subjective norms about
HPV vaccination, source of information about HPV vaccine) according to IBT. Details
about the items used to measure the eight constructs are summarized in Table 1. In
addition, there were eight items used to assess the socioeconomic, demographic, cultural
and other relevant background factors of the study participants (age, gender, religion,
marital status, occupation, educational status, awareness about HPV, knowing someone
with cancer). In case some parents were not knowledgeable about HPV, cervical cancer
and HPV vaccine, we had included basic information about HPV, cervical cancer and
HPV vaccine, into the questionnaire. This basic information about HPV, cervical cancer
and HPV vaccine would have helped parents to respond to the items used to measure
attitudes and beliefs related to HPV, cervical cancer and HPV vaccine.
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Data analysis
Data were first checked and cleaned using Stata software (Version 14, Texas,
USA). As there were missing values for some of the items used to measure the constructs
included in the SEM (benefits of HPV vaccination, barriers to HPV vaccination,
subjective norms about HPV vaccine; missing range: 0.6% to 4.9%), a multiple
imputation method (using chained equation) based on 20 iterations was used to estimate
the missing values (Azur et al., 2011). Then the cleaned data that included the estimated
missing values were transferred to Mplus version 8 for confirmatory factor analysis
(CFA) and SEM analysis (Muthén LK & Muthén BO, 2017). CFA was performed by
including each of the eight latent variables listed in Table 1 independently, and altogether
simultaneously in the measurement model. CFA was used to assess the validity of the
items employed to measure the latent variables/constructs and to check fit of the
measurement model to the data. After determining appropriate measurement models for
the latent factors using CFA (Fig 1), SEM was used to check if the proposed model (Fig
2) approximated/fit the data. SEM was also used to assess the parameters including the
factor loadings, measurement errors, disturbances, covariance and path coefficients while
examining factors that directly affect, mediate and moderate parental intention-tovaccinate daughters with HPV vaccine. All the eight latent, background, and the outcome
(willingness to vaccinate daughter with HPV vaccine) variables were entered into the
SEM model simultaneously (Fig 3). There was adequate participant to parameter ratio
(i.e. acceptable power cut off value =7) for final full SEM model (1609/47=34) (Bentler
& Chou, 1987). As the response variables were categorical in nature (multivariate
normal distribution does not exist), the variance-covariance matrix with the Weighted
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Least Squares Estimation Method was used to assess the parameters (Muthe´n et al.,
2018). Model fit statistics were assessed using Root Mean Square Error of
Approximation (RMSEA), Comparative Fit Index (CFI) and Tucker–Lewis Index (TLI).
Models were assumed good/close fit when RMSEA <0.06, and TLI and CFI >0.95 (Hu &
Bentler, 1999). Models were acceptable/fair fit if RMSEA was 0.06 to 0.08 and TLI and
CFI was between 0.90 and 0.95 (Hu & Bentler, 1999). We re-specified miss-fitting
models following the IBT soundness and modification indices outputs from Mplus
(Byrne, 2011).
Results
Characteristics of the study participants
We invited 1,650 parents to participate in the study. However, 22 parents from the
urban area and 19 parents from the rural area did not return the completed questionnaire
or had not signed the consent form, making the number of participants in this study to be
1609. Of the 1609 parents, 6.0% had formal education, 88.8% were Hindus, and 86.9%
were employed. The mean age of the parents was 38.3±6.58 years (range=23 to 75 years)
and 73.0% were females. More than two-thirds (78.0%) of the parents were willing to
vaccinate daughter with HPV vaccine. Details of the study participant characteristics are
described elsewhere (Degarege et al., 2018).
Measurement model
The measurement model that included all the items used to measure the eight
latent factors in Table 1 fit the data fairly well (RMSEA =0.032, 95% CI: 0.031, 0.034;
CFI= 0.92, TLI=0.92). However, we further modified the measurement model by
allowing some residual terms associated with similar items in the same construct to freely
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covary (Fig 1). Additionally, we modified the model by removing two items from the
construct ‘beliefs about benefits of vaccination’ (D4 and D5) and one item from the
construct ‘subjective norms about HPV vaccination’ (G1) with standardized factor
loadings (β) ≤0.3. These modifications improved the model fit statistics of the
measurement model (RMSEA =0.028, 95% CI: 0.026, 0.029; CFI= 0.95, TLI=0.95).
Items used to measure the different constructs significantly loaded with β ≥ 0.4 with the
exception of one item (D1: β =0.24).
The measurement model for each construct independently showed a good fit
between the proposed model and the data; perceived benefits of HPV vaccination
(RMSEA =0.03, CFI= 0.99, TLI= 0.98, factor loading range (β)=0.42 to 0.88), perceived
barriers to HPV vaccination (RMSEA =0.05, CFI= 0.98, TLI= 0.96, β= 0.46 to 0.80),
beliefs about severity of HPV infection or cervical cancer (RMSEA =0.00, CFI= 1.0 ,
TLI= 1.0, β=0.69 to 0.91), beliefs about susceptibility to HPV infection or cervical cancer
(RMSEA =0.06, CFI= 1.0, TLI= 0.99, β=0.69 to 0.91), beliefs about benefits of
vaccination (RMSEA = 0.00, CFI= 1.00, TLI= 1.00, β=0.41 to 0.85), beliefs about
barriers to vaccination (RMSEA = 0.00, CFI= 1.00, TLI= 1.00, β=0.50 to 0.69),
subjective norms about HPV vaccine (RMSEA = 0.11, CFI= 0.99, TLI= 0.98, β=0.61 to
0.85).
Structural model
The final full structural model based on IBT was identified; total parameter
estimated {n=184=number of factor loadings (39) + variances (65) + covariance (25) +
structural paths (55)} was less than the number of unique (co)variances of measured
variables {n=1653=57 x (57+1)/2, where 57 is the total number of measured variables}
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(Fig 3). The RMSEA statistics showed close fit of the proposed model to the observed
data covariance matrix (RMSEA: 0.025, 95% CI=0.024, 0.026). The CFI (0.92) and TLI
(0.91) values also indicated that the proposed model fit the data acceptably. Furthermore,
the ratio of the model chi-square statistic (χ2=4580.45) to the degrees of freedom
(df=1616) (χ2/df=2.83) was less than the recommended threshold for good model fit (5)
(Carmines & McIver, 1981; Marsh & Hocevar, 1985). However, the chi-square statistics
comparing the covariance matrix by the proposed model and the observed data were
significant (χ2 =3120, df=1616, p<0.01).
Factors directly affecting willingness to HPV vaccination
Willingness to vaccinate daughters with HPV vaccine was significantly greater
among parents who perceived that HPV vaccine had greater benefits (unstandardized
regression coefficient (B) = 0.51, standardized regression coefficient (β) = 0.39, p <0.001
for both) and among those who received information about HPV vaccine from several
sources (B = 0.32, β = 0.240, p <0.001 for both). On the other hand, lower willingness to
vaccinate daughters was observed among parents expressing greater perceived barriers to
vaccinating daughters with HPV vaccine (B = -0.92, β = -0.44, p <0.001 for both).
However, subjective norms related with HPV vaccine did not affect parental willingness
to vaccinate their daughters with the vaccine (B =0.05, p=0.412, β = -0.44, p=0.411)
(Table 2 and Fig 3).
Factors indirectly affecting willingness to HPV vaccination
Parental beliefs about benefits (B =0.39, β =0.20) or barriers (B = -1.04, β = -0.25)
to vaccination, and that HPV infection and cervical cancer are severe (B =0.26, β = 0.20),
significantly and indirectly affected their willingness to vaccinate daughters with HPV
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vaccine (p <0.001 for all) (Table 2 and Fig 3). The effect of parental beliefs about
benefits of vaccination on their willingness to vaccinate daughters with HPV vaccine was
significantly mediated by their perceptions about the benefits (B = 0.40, β =0.20, p
<0.001 for both) or barriers (B = -0.14, p =0.013; β =-0.08, p=0.004) to HPV vaccination,
and parental sources of information about HPV vaccine (B =0.13; β =0.07, p<0.001 for
both). The effect of the parental beliefs about barriers to vaccination on their willingness
to vaccinate daughters with HPV vaccine was also significantly ((p <0.001 for all)
mediated by their perception about the benefits (B = 0.70; β = 0.17) or barriers (B = 1.80; β =-0.43) to HPV vaccination. Similarly, the effect of parental beliefs that HPV
infection or cervical cancer are severe on their willingness to vaccinate daughters with
HPV vaccine was significantly mediated by their perception about the benefits (B = 0.24;
β =0.18, p<0.001 for both) or barriers (B = -0.07, p =0.022; β = -0.05, p=0.02) to HPV
vaccination, and sources of information about HPV vaccine (B = 0.09; β =0.07, p<0.001
for both).
Belief that daughters are susceptible to HPV infection or cervical cancer, that
HPV infection or cervical cancer are severe, and beliefs about benefits or barriers to
vaccination were significantly (p<0.01for all) positively related to parental perceived
benefits, and barriers to HPV vaccination, as well as sources of information about the
vaccine (Table 3).
Effect of background factors on beliefs about HPV infection, cervical cancer, and
vaccination
Muslims were more likely to perceive that their daughters were susceptible to
HPV infection or cervical cancer (B = 0.38, p =0.001; β =0.50, p =0.001), and were less
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likely to have negative beliefs about vaccination (B = -0.13, p =0.027; β = -0.51, p
=0.019), but were also less likely to expect that other people will recommend HPV
vaccination for their daughters (B = -0.40, p =0.027; β = -0.64, p <0.001) as compared to
non-Muslims (Hindus and Christians). Parents who were aware of HPV were more likely
to believe that their daughters were susceptible to HPV infection or cervical cancer (B =
0.29, p =0.008; β = 0.38, p=0.007). An increase in the educational status of the parents
was also associated with an increase in parental beliefs that HPV infection and cervical
cancer are severe (B = 0.17, p =0.008; β =0.22, p=0.007).
There was significant interaction between the area where the participants lived
and awareness about HPV in predicting parental beliefs about severity of HPV infection
or cervical cancer (B = 0.25, p =0.035; β = 0.33, p=0.034) (Table 5). Similarly, there was
significant interaction between the area where participants lived and awareness about
someone with cancer in predicting parental beliefs about susceptibility of their daughters
to HPV infection or cervical cancer (B = 0.33, p =0.037; β = 0.14, p =0.023), and parental
beliefs about barriers to vaccination (B = -0.14, p =0.026; β = -0.18, p=0.017). There was
also significant interaction between the area of residence and religion in predicting norms
related to vaccinating of daughters with HPV vaccine (B =0.43, p =0.001; β = 0.19, p=
0.001).
Discussion
In this cross-sectional survey of parents of adolescent girls in Mysore district,
India, parental perception about the benefits of HPV vaccination and sources of
information about HPV vaccine were the strongest direct positive predictors of parental
intention-to-vaccinate daughters with HPV vaccine. Parental beliefs about severity of
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HPV infection or cervical cancer, and beliefs about benefits of vaccination in general
were indirect positive predictors of intention-to-vaccinate. Studies among parents in
another region of India (Madhivanan et al., 2009), Hong Kong, China (Wang et al.,
2017), Indonesia (Jaspers et al., 2011) and Thailand (Charakorn et al., 2011; Grandah et
al., 2018; Juntasopeepun & Thana, 2018) also also showed a positive relationship
between attitudes about benefits of HPV vaccine (e.g. effective, prevent HPV infection
and cervical cancer, affordable) and parents’ intention-to-vaccinate with HPV vaccine.
Acceptance of HPV vaccination among the Indonesian (Jaspers et al., 2011) and Japanese
(Hanley et al., 2012) parents was also positively related with their attitudes about HPV
vaccine (e.g. effective, prevent HPV infection and cervical cancer, important, affordable)
and beliefs about severity of cervical cancer.
However, perceived barriers to HPV vaccination, which was measured by
assessing parental negative attitudes about HPV vaccine – side effects, high cost, low
family support, low risk of HPV infection/cervical cancer, not enough information about
HPV vaccine, negatively predicted intention-to-vaccinate with HPV vaccine. The more
parents’ attitudes were negative towards the HPV vaccine, the less they accepted it. In
addition, parents who had negative beliefs about vaccination in general were less
interested in recommending HPV vaccine for their daughters. Studies among parents in
Mysore city (Madhivanan et al., 2009) and Andhra Pradesh, India (Paul et al., 2014) also
showed reduced acceptance of HPV vaccine among parents who had negative attitudes
about HPV vaccine. Another study among Indonesian parents reported negative parental
attitudes about HPV vaccine and vaccination in general as reasons for decreased
acceptance of the vaccine (Jaspers et al., 2011). Thai and Japanese women also reported
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negative attitudes about HPV vaccine – high cost, side effects, low efficacy as reasons for
not accepting HPV vaccine for their daughters (Charakorn et al., 2011; Hanley et al.,
2012). A study among Malaysian mothers also showed cost as a main reason for a low
intent to vaccinate children with HPV vaccine (Sam et al., 2009).
Additionally, the current study showed that area of residence significantly
moderated the effect of background factors – particularly religion, awareness about HPV
and someone with cancer, on parental beliefs about vaccination, HPV infection and
cervical cancer. The level of access to medical services, medical professionals, health
information, as well as educational level, and cultural characteristics of populations,
which can influence parental knowledge about HPV or cervical cancer and religious
practices related to beliefs about vaccination, might be different in urban and rural areas
in India (Eberhardt & Pamuk, 2004; Das & Pathak, 2012). As a result, the effect of
awareness about HPV, knowledge about someone with cancer, and religion on parental
beliefs about susceptibility and severity of HPV infection or cervical cancer, and beliefs
about vaccination may not be similar in urban and rural areas in India.
There was relatively high intention to get daughters vaccinated with HPV vaccine
(78.0%) in the current study population. This intention to vaccinate with HPV vaccine
was greater when compared to the rate reported among parents in other regions in India
(46.0% -74.0%) (Basu et al., 2011; Montgomery et al., 2015), Malaysia (65.7%) (Sam et
al., 2009) and China (26.5%) (Yu et al., 2016), but lower than the rate reported in
Indonesia (96.1%) (Jaspers et al., 2011), Japan (93.0%) (Hanley et al., 2012), and
Thailand (84%-85%) (Charakorn et al., 2011; Juntasopeepun et al., 2018). Even in
Mysore district, the intention to HPV vaccination rate was greater among parents who

79

were living in the rural (79.9%) (Degarege et al., 2018) than those living in the urban
(71.1%) area (Madhivanan et al., 2014). This difference in the intention to HPV
vaccination rate among parents in different regions of Mysore district in India or South
Asian countries could be attributed to differences in the level of parental
awareness/knowledge and beliefs/attitudes related to the risk and severity of HPV
infection and cervical cancer as well as HPV vaccination. Indeed, intention to vaccination
of daughters with HPV vaccine among Indian parents increased from 24% to 74% after
parents read fact sheet about the relationship between HPV infection and cervical cancer
as well as availability of effective and safe vaccine to protect cervical cancer (Basu et al.,
2011).
These findings have possible implications both for practice and research. Health
education programs aimed at reducing negative attitudes of parents about HPV vaccine
(e.g. side effects, low efficacy) and vaccination in general (e.g. too many vaccines, get
the disease and protected naturally), in addition to teaching facts about the vaccine, as
well as creating awareness/knowledge about HPV infection and cervical cancer are
important in India, particularly to those living in Mysore district, to improve their
willingness to vaccinate their daughters with HPV vaccine. The health education program
would be more beneficial (influential) if it targeted rural communities where the level of
awareness/knowledge about HPV and cervical cancer might be low, and religious
practices/cultures that do not encourage HPV vaccination may prevail. Furthermore, the
current study suggests that the IBT can be appropriate to guide future studies that
examine factors affecting HPV vaccine acceptability among the Indian communities.

80

This study involved a randomly selected and reasonably large sample size and a
high response rate. The analysis was done following a robust theory-based technique.
Despite the above strengths, findings in this study should be interpreted in light of the
following limitations. Although the RMSEA, CFI, and TLI values suggested that the
proposed model based on the IBT fits with the current data, the chi-square statistics
indicated significant difference in the covariance matrix by the proposed model and the
observed data. However, as the chi-square test is an approximation and sensitive to
sample size, the current model is still reasonable to assume to be valid to explain the data.
With the value of χ2/df= (4580.45/1616) being less than five, some scholars consider it a
good fit (Carmines & McIver, 1981; Marsh & Hocevar, 1985). In addition, due to the
cross-sectional nature of the study and lack of actual HPV vaccine uptake data, we are
unable to establish cause and effect relationship between the variables and fully test the
IBT. Moreover, interpretation of mediating effects must be done in the context of a crosssectional study. Furthermore, only parents of school going adolescent girls participated in
this study. This may affect generalizability of the current findings to parents who do not
have daughters attending schools. Finally, the data were self-reported. Thus, there could
be some level of social desirability and information bias in responses. Furthermore,
suspension of HPV vaccination in India in 2010 might have affected the beliefs and
attitudes of parents about HPV infection, cervical cancer and HPV vaccine. Finally, the
data for this study were collected between February 2010 and October 2011. There may
have been changes in the parental opinion/views regarding cervical cancer, HPV
infection and vaccine, and vaccination in general in the past years. This delay in the time
for reporting the results after the data were collected may affect policy measures designed

81

to change misperceptions of parents related to HPV infection, cervical cancer and HPV
vaccine in order to improve HPV vaccine acceptance among parents in Mysore, India.
Conclusions
The current study identified parental perception about the benefits of HPV
vaccination, and sources of information about HPV vaccine as the strongest direct
positive predictors of intention-to-vaccinate girls with HPV vaccine, and parental beliefs
about severity of HPV infection or cervical cancer, and beliefs about benefits of
vaccination in general as indirect positive predictors of intention to HPV vaccination.
Perceived barriers to HPV vaccination negatively predicted parental intention to
vaccinate daughters with HPV vaccine. The study also confirmed complementary
relationships of the socioeconomic factors and constructs related to beliefs and attitudes
suggested by the IBT. However, further longitudinal studies that measure HPV vaccine
uptake status is important to examine the causal influence of constructs of IBT on one
another, and to fully verify whether IBT can be applied to appropriately guide studies that
examine factors affecting HPV vaccination in the Indian population.
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Area
Age
Susceptible to HPV Infection n or
cervical cancer

Gender

Perceived benefits of
HPV vaccination

Education
status
Severity of HPV infection
or cervical cancer

Occupation

Perceived barriers to
HPV vaccination

Religion
Benefits of vaccination

Marital status

Sources of information
about HPV vaccination

Know someone
with cancer

Barriers to vaccination

Subjective norms
about HPV vaccination

Awareness
about HPV
direct effect

indirect effect

moderating effect

Fig 1. Proposed integrative behavior theory derived model for understanding factors predicting parental
intention-to-vaccinate daughters with HPV vaccine
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Parental
intention
to
vaccinate
daughters
with HPV
vaccine

Fig 2. Measurement model
of latent factors predicting
parental intention-tovaccinate daughters with
HPV vaccine in Mysore,
India 2010/2011
L1=Susceptibility to
HPV/cervical cancer
L2=Severity of HPV/cervical
cancer

L3=Benefits of vaccination
L4=Barriers to vaccination
L5=Benefits of HPV
vaccination L6=Barriers to
HPV vaccination
L7=Subjective norms about
HPV vaccination
L8=Source of information
about HPV vaccine
* details of names of items
measuring each latent factor
is provided in table 1
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Fig 3. Structural equation model explaining factors predicting parental intention-tovaccinate daughters with HPV vaccine in Mysore, India 2010/2011
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Table 1. Latent variables/constructs and the corresponding measuring items along with
their responses/scores
Item Item
label
Susceptibility to A1
It is possible that my daughter will get cervical cancer
HPV/cervical
in the future.
cancer (L1)
Constructs

A2
A3

Severity of
HPV/cervical
cancer (L2)

A4
B1

B2
B3
B4
Benefits of
vaccination
(L3)

C1

C2
C3
C4
C5
C6
Barriers to
vaccination
(L4)

D1

D2
D3
D4
D5
Benefits of
HPV
vaccination
(L5)

It is likely that my daughter may get cervical cancer
someday.
It is likely that my daughter may get HPV infection in
the future.
My daughter may be at risk of getting HPV infection
I believe that cervical cancer is a serious disease

I believe that cervical cancer can be extremely harmful
I believe that HPV infection can be extremely harmful
I believe that HPV infection can cause serious health
problem
Vaccines are effective in preventing disease

It is very important that my children receive all their
vaccination
Vaccine is one way that parents can ensure their child
health
I have a responsibility, to have my children vaccinated
for the protection of all children.
The government does a good job providing vaccination
& health services
I would feel resp, if anything bad happened I did not
have my child
I am concerned about vaccine side effects

Responses/Scores

1=disagree,
2=do not know,
3=agree

1=disagree,
2=do not know,
3=agree

1=no, 2=not
sure, 3=yes

1=no, 2=not
sure, 3=yes

I am afraid of vaccination my children
It is better to get the disease and get protected naturally
vaccine
I would feel resp, if anything bad happened I had my
child vaccinated
There are too many vaccine already included childhood
vaccine schedule

E1

Recommendation from doctor or nurse
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1= not
important all,
2=important
3=very
important

E2
E3
E4
E5
E6
E7

Barriers to
HPV
vaccination
(L6)

Subjective
norms about
HPV
vaccination
(L7)

E8
F1

F2
F3
F4
F5
F6
F7
F8
G1

G2
G3
G4
G5
G6
G7
Source of
information
about HPV
vaccine (L8)

Worry about daughter getting cervical cancer
Belief that vaccine will be safe
Worry that daughter may become sexually active
Support from family members to vaccinate your
daughter
Learning more about the relationship of HPV to cervical
cancer
Government approval of vaccine safety and
effectiveness
Belief that vaccine will prevent cervical cancer

High cost of HPV vaccination
Low risk that daughter will be infected with HPV
Low risk that daughter will get cervical cancer
Family will disapprove of getting daughter
Injection may cause pain to my daughter
Not enough information available about HPV vaccine
Worried about safety of the HPV vaccine
Vaccination may not be effective

1=no, 2=don’t
know, 3=yes
Do you think your doctor want to vaccinate your
daughter?
Do you think your spouse want to you vaccinate?
Do you think your friends want you to vaccinate?
do you think your father and mother want you to
vaccinate?
Do you think other relatives want you to vaccinate?
Do you think your In-laws want to vaccinate?
Do you think your neighbors want you to vaccinate
your daughter?

H1

H2
H3
H4
H5
H6
H7
H8

1= not
important all,
2=important
3=very
important

0=no, 1=yes

I get my information from Television
I get my information about from newspaper
I get my information about from internet
I get my information about vaccine from doctor
I get my information from Anganwadi teacher or worker
I get my information from friends
I get my information from daughter at school
I get my information from family member/relative
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Table 2 Unstandardized (B) and standardized (β) effect of factors affecting willingness to
HPV vaccination for the structural model
Factors

Willingness to HPV vaccination
B (95% CI)

β (95% CI)

Benefits of HPV vaccination

0.51 (0.29, 0.74)

0.39 (0.23, 0.55)

Barriers to HPV vaccination

-0.92 (-1.24, 0.59)

Direct

Information about HPV

-0.44 (-0.59, -0.30)

0.32 (0.19, 0.44)

0.24 (0.15, 0.34)

0.05 (-0.07, 0.17)

-0.44 (-0.04, 0.10)

vaccination
Norms about HPV vaccination

Indirect

Mediators

Beliefs about benefits of

Benefits of HPV vaccination

vaccination

Barriers to HPV vaccination -0.14 (-0.25, -0.03) -0.07 (-0.12, -0.02)
Information about HPV

0.40 (0.19, 0.60)

0.20 (0.11, 0.29)

0.13 (0.06, 0.21)

0.07 (0.03, 0.10)

Sum of indirect effect

0.39 (0.22, 0.56)

0.20 (0.13, 0.27)

Beliefs about barriers to

Benefits of HPV vaccination

0.70 (0.28, 1.12)

0.17 (0.09, 0.25)

vaccination

Barriers to HPV vaccination -1.80 (-2.58, -1.01) -0.43 (-0.57, -0.30)

vaccination

Information about HPV

0.06 (-0.03, 0.14) 0.01 (-0.01, 0.03)

vaccination
Sum of indirect effect

-1.04 (-1.51, -0.57) -0.25 (-0.34, -0.16)

Beliefs about susceptibility

Benefits of HPV vaccination

to HPV and cervical cancer

Barriers to HPV vaccination -0.12 (-0.18, -0.05) -0.09 (-0.13, -0.04)
Information about HPV

0.14 (0.07, 0.21)

0.10 (0.06, 0.15)

-0.01 (-0.03, 0.02) -0.01 (-0.02, 0.01)

vaccination
Sum of indirect effect

0.02 (-0.05, 0.08) 0.01 (-0.03, 0.06)

Beliefs about severity of

Benefits of HPV vaccination

0.24 (0.13, 0.35)

HPV and cervical cancer

Barriers to HPV vaccination -0.07 (-0.13, -0.01) -0.05 (-0.09, -0.01)
Information about HPV

0.18 (0.10, 0.26)

0.09 (0.05, 0.14)

0.07 (0.04, 0.100)

0.26 (0.17, 0.36)

0.20 (0.13, 0.26)

vaccination
Sum of indirect effect
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Table 3. Unstandardized (B) and standardized effects (β) of parental beliefs about HPV,
cervical cancer and vaccination on parental attitudes and source of information related to
HPV vaccination for the structural model
Belief (exposure)

Attitude/information (outcome)

B (95% CI)

β (95% CI)

Benefits of vaccination Perceived benefits of HPV vaccination 0.79 (0.55, 1.01) 0.52 (0.44, 0.61)
Perceived barriers to HPV vaccination 0.15 (0.05, 0.26) 0.16 (0.06, 0.26)
Sources of information about HPV

0.42 (0.25, 0.59) 0.28 (0.19, 0.37)

vaccination
Barriers to vaccination Perceived benefits of HPV vaccination 1.37 (0.83, 1.90) 0.44 (0.36, 0.52)
Perceived barriers to HPV vaccination 1.96 (1.32, 2.60) 0.98 (0.96, 0.99)
Sources of information about HPV

0.17 (-0.08, 0.43) 0.06 (-0.02, 0.13)

vaccination
Susceptibility to HPV

Perceived benefits of HPV vaccination 0.28 (0.20, 0.35) 0.27 (0.20, 0.34)

infection or cervical
cancer
Perceived barriers to HPV vaccination 0.13 (0.08, 0.18) 0.20 (0.12, 0.27)
Sources of information about HPV

-0.03 (-0.10,0.05) -0.03 (-0.10,0.05)

vaccination
Severity of HPV

Perceived benefits of HPV vaccination 0.47 (0.36, 0.57) 0.47 (0.39, 0.54)

infection or cervical
cancer
Perceived barriers to HPV vaccination 0.07 (0.02, 0.13) 0.11 (0.03, 0.20)
Sources of information about HPV
vaccination
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0.29 (0.20, 0.37) 0.28 (0.21, 0.36)

Table 4. Unstandardized (B) and standardized (β) effects of background factors on
parental beliefs about HPV, cervical cancer and vaccination for the Structural Model

B (95% CI)

β (95% CI)

Susceptibility to HPV/cervical cancer

-0.02 (-0.03, 0.001)

-0.02 (-0.04, 0.002)

Severity of HPV/cervical cancer

0.02 (-0.001, 0.03)

0.020 (-0.002, 0.041)

Benefits of vaccination

0.08 (-0.003, 0.02)

0.02 (-0.01, 0.04)

Barriers to vaccination

-0.002 (-0.01, 0.004) -0.01 (-0.03, 0.02)

Subjective norms about HPV

-0.004 (-0.02,0.01)

-0.01 (-0.03, 0.01)

Susceptibility to HPV/cervical cancer

-0.08 (-0.36, 0.20)

-0.11 (-0.48, 0.26)

Severity of HPV/cervical cancer

0.023 (-0.23, 0.28)

0.03 (-0.30, 0.361)

Benefits of vaccination

-0.006 (-0.19, 0.18)

-0.01 (-0.36, 0.34)

Barriers to vaccination

-0.001 (-0.09, 0.09)

-0.004 (-0.38, 0.37)

Subjective norms about HPV

0.01 (-0.18, 0.20)

0.02 (-0.29, 0.32)

Susceptibility to HPV/cervical cancer

-0.05 (-0.18, 0.08)

-0.07 (-0.24, 0.11)

Severity of HPV/cervical cancer

0.17 (0.04, 0.29)

0.22 (0.06, 0.38)

Benefits of vaccination

0.09 (-0.004, 0.19)

0.18 (-0.003, 0.36)

Barriers to vaccination

-0.04 (-0.08, 0.01)

-0.15 (-0.32, 0.03)

Subjective norms about HPV

0.03 (-0.07, 0.12)

0.05 ( -0.10, 0.20)

Susceptibility to HPV/cervical cancer

-0.09 (-0.28, 0.11)

-0.11 (-0.37, 0.15)

Severity of HPV/cervical cancer

-0.09 (-0.28, 0.11)

-0.11 (-0.36, 0.14)

Benefits of vaccination

-0.140 (-0.28, 0.00)

-0.27 (-0.54, -0.01)

Barriers to vaccination

-0.01 (-0.09, 0.06)

-0.06 (-0.36, 0.24)

Subjective norms about HPV

0.03 (-0.13, 0.19)

0.05 (-0.20, 0.30)

Susceptibility to HPV/cervical cancer

0.38 (0.15, 0.61)

0.50 (0.20, 0.80)

Severity of HPV/cervical cancer

0.12 (-0.13, 0.37)

0.16 (-0.17, 0.48)

Benefits of vaccination

-0.14 (-0.33, 0.06)

-0.26 (-0.64, 0.12)

Background beliefs/norm (outcome)
(exposure)
Age

vaccination
Gender

vaccination
Education

vaccination
Occupation

vaccination
Religion
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Barriers to vaccination

-0.13 (-0.24, -0.01)

-0.51 (-0.93, -0.09)

Subjective norms about HPV

-0.40 (-0.61, -0.19)

-0.64 (-0.97, -0.31)

Susceptibility to HPV/cervical cancer

-0.16 (-0.49, 0.17)

-0.21 (-0.64, 0.23)

Severity of HPV/cervical cancer

-0.20 (-0.50, 0.10)

-0.27 ( -0.66, 0.12)

Benefits of vaccination

0.09 (-0.12, 0.30)

0.18 (-0.23, 0.58)

Barriers to vaccination

0.04 (-0.07, 0.15)

0.17 ( -0.28, 0.62)

Subjective norms about HPV

-0.01 (-0.26, 0.23)

-0.02 (-0.42, 0.37)

Susceptibility to HPV/cervical cancer

-0.53 (-1.53, 0.48)

-0.69 (-2.01, 0.62)

Severity of HPV/cervical cancer

0.41 (-0.53, 1.34)

0.53 (-0.69, 1.74)

Benefits of vaccination

-0.03 (-0.71, 0.65)

-0.05 (-1.37, 1.26)

Barriers to vaccination

0.15 (-0.20, 0.50)

0.62 (-0.78, 2.02)

Subjective norms about HPV

-0.30 (-1.03, 0.43)

-0.48 (-1.65, 0.69)

Susceptibility to HPV/cervical cancer

-0.25 (-0.50, 0.00)

-0.33 (-0.66, -0.003)

Severity of HPV/cervical cancer

0.12 (-0.17, 0.40)

0.15 (-0.22 , 0.52)

Benefits of vaccination

0.11 (-0.10, 0.31)

0.20 (-0.18, 0.60)

Barriers to vaccination

0.07 (-0.03, 0.17)

0.28 (-0.12, 0.69)

Subjective norms about HPV

-0.05 (-0.26, 0.17)

-0.07 (-0.41, 0.27)

Susceptibility to HPV/cervical cancer

0.29 (0.08,0.50)

0.38 (0.10, 0.66)

Severity of HPV/cervical cancer

-0.03 (-0.24, 0.17)

-0.04 (-0.31, 0.22)

Benefits of vaccination

-0.001 (-0.15, 0.15)

-0.002 (-0.29, 0.29)

Barriers to vaccination

-0.03 (-0.11, 0.06)

-0.10 (-0.42, 0.22)

Subjective norms about HPV

0.04 (-0.13, 0.20)

0.06 ( -0.21, 0.33)

vaccination
Marital
status

vaccination
Region

vaccination
Knowing
someone
with cancer

vaccination
Heard
about HPV

vaccination
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Table 5. Unstandardized and standardized effects of interaction between area and
background factors in predicting parental beliefs about HPV, cervical cancer and
vaccination for the structural model
Background

Beliefs and norm factors (outcome)

B (95% CI)

β (95% CI)

factors X
Area
(exposure)
Age

Susceptibility to HPV/cervical cancer 0.011 (-0.01, 0.03)

0.25 (-0.16, 0.67)

Severity of HPV/cervical cancer

-0.01 (-0.03, 0.01)

-0.17 (-0.58, 0.24)

Benefits of vaccination

0.004 (-0.02, 0.02)

0.13 (-0.31, 0.57)

Barriers to vaccination

-0.002 (-0.01, 0.01) -0.15 (-0.61, 0.31)

Subjective norms about HPV

0.01 (-0.01, 0.02)

0.14 (-0.26, 0.54)

0.12 (-0.20, 0.43)

0.08 (-0.13, 0.28)

0.04 (-0.26, 0.33)

0.02 (-0.17, 0.21)

Belief about benefits of vaccination

0.10 (-0.12, 0.32)

0.10 (-0.11, 0.31)

Belief about barriers to vaccination

-0.02 (-0.12, 0.09)

-0.04 (-0.25, 0.17)

Subjective norms about HPV

0.05 (-0.17, 0.27)

0.04 (-0.13, 0.22)

Susceptibility to HPV/cervical cancer 0.03 (-0.12, 0.18)

0.03 (-0.11, 0.17)

Severity of HPV/cervical cancer

0.09 (-0.06, 0.23)

0.08 (-0.05, 0.22)

Benefits of vaccination

0.09 (-0.03, 0.20)

0.12 (-0.04, 0.27)

Barriers to vaccination

0.001 (-0.05, 0.05)

0.002 (-0.15, 0.15)

Subjective norms about HPV

-0.01 (-0.12, 0.11)

0.10 (-0.11, 0.12)

vaccination
Gender

Belief about susceptibility to HPV
infection and cervical cancer
Belief about severity of HPV
infection and cervical cancer

vaccination
Education

vaccination
Occupation

Susceptibility to HPV/cervical cancer 0.06 (-0.17, 0.28)

0.04 (-0.11, 0.18)

Severity of HPV/cervical cancer

0.06 (-0.16, 0.28)

0.04 (-0.11, 0.18)

Benefits of vaccination

0.13 (-0.03, 0.30)

0.12 (-0.04, 0.27)

Barriers to vaccination

0.00 (-0.08, 0.08)

0.00 (-0.17, 0.17)
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Subjective norms about HPV

-0.04 (-0.22, 0.14)

-0.03 (-0.17, 0.11)

0.02 (-0.26, 0.30)

0.01 (-0.09, 0.11)

-0.06 (-0.37, 0.26)

-0.02 ( -0.13, 0.09)

Belief about benefits of vaccination

-0.02 (-0.27, 0.22)

-0.01 (-0.14, 0.11)

Belief about barriers to vaccination

0.08 (-0.04, 0.20)

0.09 (-0.04, 0.22)

Subjective norms about HPV

0.43 (0.18, 0.68)

0.19 (0.08, 0.29)

vaccination
Religion

Belief about susceptibility to HPV
infection and cervical cancer
Belief about severity of HPV
infection and cervical cancer

vaccination
Marital status Susceptibility to HPV/cervical cancer 0.15 (-0.25, 0.54)

0.09 (-0.15, 0.32)

Severity of HPV/cervical cancer

0.22 (-0.15, 0.58)

0.13 (-0.09, 0.34)

Benefits of vaccination

0.05 (-0.21, 0.32)

0.05 (-0.18, 0.27)

Barriers to vaccination

-0.08 (-0.21, 0.06)

-0.14 (-0.38, 0.09)

Subjective norms about HPV

0.13 (-0.16, 0.42)

0.09 (-0.12, 0.30)

vaccination
Knowing

Susceptibility to HPV/cervical cancer 0.33 (0.04, 0.61)

0.14 (0.02, 0.25)

Severity of HPV/cervical cancer

0.14 (-0.18, 0.46)

0.06 (-0.07, 0.19)

Benefits of vaccination

-0.003 (-0.24, 0.23) -0.002 (-0.15, 0.14)

Barriers to vaccination

-0.14 (-0.26, -0.02) -0.18 (-0.32, -0.03)

Subjective norms about HPV

0.08 (-0.16, 0.32)

someone with
cancer

0.04 (-0.08, 0.16)

vaccination
Heard about

Susceptibility to HPV/cervical cancer -0.19 (-0.43, 0.05)

-0.10 (-0.23, 0.03)

Severity of HPV/cervical cancer

0.25 (0.02, 0.48)

0.13 (0.01, 0.26)

Benefits of vaccination

0.13 (-0.05, 0.31)

0.10 (-0.04, 0.24)

Barriers to vaccination

0.01 (-0.08, 0.10)

0.02 (-0.13, 0.17)

Subjective norms about HPV

-0.05 (-0.24, 0.14)

-0.03 (-0.16, 0.09)

HPV

vaccination
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CONCLUSIONS
Willingness to vaccinate daughters with HPV vaccine was high among parents in
Mysore district, India. Parental perception about the benefits of HPV vaccination, and
sources of information about HPV vaccine were the strongest direct positive predictors of
parental intention-to-vaccinate daughters. Parental beliefs about severity of HPV
infection or cervical cancer, and beliefs about benefits of vaccination also indirectly
positively affected intention-to-vaccinate girls with HPV vaccine. However, perceived
barriers to HPV vaccination negatively predicted intention-to-vaccinate.
In the rural area, willingness to vaccinate daughters with HPV vaccine was
particularly greater among parents who believed that HPV vaccine was safe; or daughter
may become sexually active; or if they have support from other family members to
vaccinate their daughter; or if HPV infection causes severe health problems. On the other
hand, willingness to vaccinate daughters with HPV vaccine was particularly lower among
rural parents who were older or if they believed that there was low risk that a daughter
would get cervical cancer; or if family would disapprove of getting a daughter
vaccinated; or if the injection might cause pain.
In addition, the current study confirmed evidence of urban-rural differences in
the parental attitudes and beliefs about HPV, cervical cancer and HPV vaccine. When
compared to parents living in rural regions, urban parents were more likely to believe that
HPV infection and cervical cancer caused serious health problems, but they were less
likely to agree that HPV vaccination would make girls sexually active. Moreover, the
current study showed evidence that area of residence moderated the effect of: i)
awareness about HPV on parental beliefs about severity of HPV infection or cervical
98

cancer; ii) knowing someone with cancer on parental beliefs about barriers to
vaccination, and parents’ perception about susceptibility of daughters to HPV infection or
cervical cancer; and iii) religion on parental norms related to HPV vaccination.
Future public health education interventions tailored against parental negative
attitudes and beliefs about HPV vaccine and vaccination in general will be important for
the Indian communities to promote HPV vaccination and reduce HPV infection related
cancers in the country. Health education in the rural area should target older aged parents
as well as extended family members to ensure increased vaccination uptake.
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